NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|2024423680|ref|XP_040560473|]
View 

2-5A-dependent ribonuclease isoform X1 [Gallus gallus]

Protein Classification

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
RNase_RNase-L cd10423
RNase domain (also known as the kinase extension nuclease domain) of RNase L; Ribonuclease L ...
576-687 1.26e-49

RNase domain (also known as the kinase extension nuclease domain) of RNase L; Ribonuclease L (RNase L), sometimes referred to as the 2-5A-dependent RNase, is a highly regulated, latent endoribonuclease (thus the 'L' in RNase L) and is widely expressed in most mammalian tissues. It is involved in the mediation of the antiviral and pro-apoptotic activities of the interferon-inducible 2-5A system, which blocks infections by certain types of viruses through cleavage of viral and cellular single-stranded RNA. RNase L is unique in that it is composed of three major domains; N-terminus regulatory ankyrin repeat domain (ARD), followed by a linker, a protein kinase (PK)-like domain and a C-terminal ribonuclease (RNase) domain. The RNase domain has homology with IRE1, also containing both a kinase and an endoribonuclease, that functions in the unfolded protein response (UPR). RNase L has been shown to have an impact on the pathogenesis of prostate cancer; the RNase L gene, RNASEL, has been identified as a strong candidate for the hereditary prostate cancer 1 (HPC1) allele. The broad range of biological functions of RNase offers a possibility for RNase L as a therapeutic target.


:

Pssm-ID: 199218  Cd Length: 119  Bit Score: 169.19  E-value: 1.26e-49
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 576 QRKFNTLKNIWNKIKDLTDDDKKDAYNTLNAGEPIP---YPNWTKQIDPEILCIMSNSSVGKKFIYTKKITDLLRLIRNL 652
Cdd:cd10423     1 ENRYRTLRNVGNESDIKTRDDKSDILRLLQAGKSECsrsFPNWTSKIDKEVMDIMNKFYEKKKFFYQDTVGDLLKFIRNL 80
                          90       100       110
                  ....*....|....*....|....*....|....*....
gi 2024423680 653 DEH----PNKRISEITGDYAEYFLKLFPKLTIYVYNRLR 687
Cdd:cd10423    81 GEHideeKNKRMKEIIGDPSEYFQKTFPDLVIYVYKKLR 119
ANKYR COG0666
Ankyrin repeat [Signal transduction mechanisms];
18-307 3.18e-42

Ankyrin repeat [Signal transduction mechanisms];


:

Pssm-ID: 440430 [Multi-domain]  Cd Length: 289  Bit Score: 155.11  E-value: 3.18e-42
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  18 QRAESIASELNDALRYGQREKVLELLENGADVNSKVEFGWTPLHSAVQSGDKEMVQLLLDKGACPHARKDNGGTVFIEAA 97
Cdd:COG0666    16 LLLLLLALLLLAAALLLLLLLLLLLLLALLALALADALGALLLLAAALAGDLLVALLLLAAGADINAKDDGGNTLLHAAA 95
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  98 MVGNVEILELLFGCGFNINDSDNNGFTAFMEAAWYGKEEALRFLHSKGADVNMRrnaseekkklNKGGKAALMDACWGGH 177
Cdd:COG0666    96 RNGDLEIVKLLLEAGADVNARDKDGETPLHLAAYNGNLEIVKLLLEAGADVNAQ----------DNDGNTPLHLAAANGN 165
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 178 FSVVKTLIqEMGADVNICDNEGRNALIHAlkdyqrgkSESDVFEIGRFLLDHGIDVNCKDEAGRTALILAVQRKNTSLVK 257
Cdd:COG0666   166 LEIVKLLL-EAGADVNARDNDGETPLHLA--------AENGHLEIVKLLLEAGADVNAKDNDGKTALDLAAENGNLEIVK 236
                         250       260       270       280       290
                  ....*....|....*....|....*....|....*....|....*....|
gi 2024423680 258 ALLDREdINIDDADEDGQTALMVAVEKNAYDIAEMLCKKGARADTGKLIA 307
Cdd:COG0666   237 LLLEAG-ADLNAKDKDGLTALLLAAAAGAALIVKLLLLALLLLAAALLDL 285
PKc_like super family cl21453
Protein Kinases, catalytic domain; The protein kinase superfamily is mainly composed of the ...
375-507 3.36e-09

Protein Kinases, catalytic domain; The protein kinase superfamily is mainly composed of the catalytic domains of serine/threonine-specific and tyrosine-specific protein kinases. It also includes RIO kinases, which are atypical serine protein kinases, aminoglycoside phosphotransferases, and choline kinases. These proteins catalyze the transfer of the gamma-phosphoryl group from ATP to hydroxyl groups in specific substrates such as serine, threonine, or tyrosine residues of proteins.


The actual alignment was detected with superfamily member cd00180:

Pssm-ID: 473864 [Multi-domain]  Cd Length: 215  Bit Score: 57.67  E-value: 3.36e-09
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 375 SQGDIYLGLY--DGMEVAV-------WIHRRAEGVKEKTFLDQCgSCEHLLKLFQSEQEKGCMYLCFTLWE-KNLEEHLQ 444
Cdd:cd00180     5 SFGKVYKARDkeTGKKVAVkvipkekLKKLLEELLREIEILKKL-NHPNIVKLYDVFETENFLYLVMEYCEgGSLKDLLK 83
                          90       100       110       120       130       140
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 2024423680 445 D---PEDQKDYKGILKMIFQAVRELHSLGFAHQALHPKNFLIDLGGKIYLADFDNTRKLTEGKTEL 507
Cdd:cd00180    84 EnkgPLSEEEALSILRQLLSALEYLHSNGIIHRDLKPENILLDSDGTVKLADFGLAKDLDSDDSLL 149
PKc_like super family cl21453
Protein Kinases, catalytic domain; The protein kinase superfamily is mainly composed of the ...
461-577 2.22e-08

Protein Kinases, catalytic domain; The protein kinase superfamily is mainly composed of the catalytic domains of serine/threonine-specific and tyrosine-specific protein kinases. It also includes RIO kinases, which are atypical serine protein kinases, aminoglycoside phosphotransferases, and choline kinases. These proteins catalyze the transfer of the gamma-phosphoryl group from ATP to hydroxyl groups in specific substrates such as serine, threonine, or tyrosine residues of proteins.


The actual alignment was detected with superfamily member cd05601:

Pssm-ID: 473864 [Multi-domain]  Cd Length: 328  Bit Score: 56.55  E-value: 2.22e-08
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 461 QAVRELHSLGFAHQALHPKNFLIDLGGKIYLADFDNTRKLTEGKT---------------ELINKdLENLSK-------- 517
Cdd:cd05601   113 LAIHSLHSMGYVHRDIKPENILIDRTGHIKLADFGSAAKLSSDKTvtskmpvgtpdyiapEVLTS-MNGGSKgtygvecd 191
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 518 -----LMLYVLTGGKKPLNEVSTEDMAAVSMDH-------------EEALDLIDSLASH-DER-GLEGLSEHPYF----W 573
Cdd:cd05601   192 wwslgIVAYEMLYGKTPFTEDTVIKTYSNIMNFkkflkfpedpkvsESAVDLIKGLLTDaKERlGYEGLCCHPFFsgidW 271

                  ....
gi 2024423680 574 SKQR 577
Cdd:cd05601   272 NNLR 275
 
Name Accession Description Interval E-value
RNase_RNase-L cd10423
RNase domain (also known as the kinase extension nuclease domain) of RNase L; Ribonuclease L ...
576-687 1.26e-49

RNase domain (also known as the kinase extension nuclease domain) of RNase L; Ribonuclease L (RNase L), sometimes referred to as the 2-5A-dependent RNase, is a highly regulated, latent endoribonuclease (thus the 'L' in RNase L) and is widely expressed in most mammalian tissues. It is involved in the mediation of the antiviral and pro-apoptotic activities of the interferon-inducible 2-5A system, which blocks infections by certain types of viruses through cleavage of viral and cellular single-stranded RNA. RNase L is unique in that it is composed of three major domains; N-terminus regulatory ankyrin repeat domain (ARD), followed by a linker, a protein kinase (PK)-like domain and a C-terminal ribonuclease (RNase) domain. The RNase domain has homology with IRE1, also containing both a kinase and an endoribonuclease, that functions in the unfolded protein response (UPR). RNase L has been shown to have an impact on the pathogenesis of prostate cancer; the RNase L gene, RNASEL, has been identified as a strong candidate for the hereditary prostate cancer 1 (HPC1) allele. The broad range of biological functions of RNase offers a possibility for RNase L as a therapeutic target.


Pssm-ID: 199218  Cd Length: 119  Bit Score: 169.19  E-value: 1.26e-49
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 576 QRKFNTLKNIWNKIKDLTDDDKKDAYNTLNAGEPIP---YPNWTKQIDPEILCIMSNSSVGKKFIYTKKITDLLRLIRNL 652
Cdd:cd10423     1 ENRYRTLRNVGNESDIKTRDDKSDILRLLQAGKSECsrsFPNWTSKIDKEVMDIMNKFYEKKKFFYQDTVGDLLKFIRNL 80
                          90       100       110
                  ....*....|....*....|....*....|....*....
gi 2024423680 653 DEH----PNKRISEITGDYAEYFLKLFPKLTIYVYNRLR 687
Cdd:cd10423    81 GEHideeKNKRMKEIIGDPSEYFQKTFPDLVIYVYKKLR 119
ANKYR COG0666
Ankyrin repeat [Signal transduction mechanisms];
18-307 3.18e-42

Ankyrin repeat [Signal transduction mechanisms];


Pssm-ID: 440430 [Multi-domain]  Cd Length: 289  Bit Score: 155.11  E-value: 3.18e-42
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  18 QRAESIASELNDALRYGQREKVLELLENGADVNSKVEFGWTPLHSAVQSGDKEMVQLLLDKGACPHARKDNGGTVFIEAA 97
Cdd:COG0666    16 LLLLLLALLLLAAALLLLLLLLLLLLLALLALALADALGALLLLAAALAGDLLVALLLLAAGADINAKDDGGNTLLHAAA 95
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  98 MVGNVEILELLFGCGFNINDSDNNGFTAFMEAAWYGKEEALRFLHSKGADVNMRrnaseekkklNKGGKAALMDACWGGH 177
Cdd:COG0666    96 RNGDLEIVKLLLEAGADVNARDKDGETPLHLAAYNGNLEIVKLLLEAGADVNAQ----------DNDGNTPLHLAAANGN 165
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 178 FSVVKTLIqEMGADVNICDNEGRNALIHAlkdyqrgkSESDVFEIGRFLLDHGIDVNCKDEAGRTALILAVQRKNTSLVK 257
Cdd:COG0666   166 LEIVKLLL-EAGADVNARDNDGETPLHLA--------AENGHLEIVKLLLEAGADVNAKDNDGKTALDLAAENGNLEIVK 236
                         250       260       270       280       290
                  ....*....|....*....|....*....|....*....|....*....|
gi 2024423680 258 ALLDREdINIDDADEDGQTALMVAVEKNAYDIAEMLCKKGARADTGKLIA 307
Cdd:COG0666   237 LLLEAG-ADLNAKDKDGLTALLLAAAAGAALIVKLLLLALLLLAAALLDL 285
PHA03095 PHA03095
ankyrin-like protein; Provisional
37-296 7.58e-19

ankyrin-like protein; Provisional


Pssm-ID: 222980 [Multi-domain]  Cd Length: 471  Bit Score: 90.08  E-value: 7.58e-19
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  37 EKVLELLENGADVNSKVEFGWTPLHSAVQSG---DKEMVQLLLDKGACPHARKDNGGTVFIEAAMVGNVE-ILELLFGCG 112
Cdd:PHA03095   28 EEVRRLLAAGADVNFRGEYGKTPLHLYLHYSsekVKDIVRLLLEAGADVNAPERCGFTPLHLYLYNATTLdVIKLLIKAG 107
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 113 FNINDSDNNGFTAF------MEAawygKEEALRFLHSKGADVNMR--------------RNASEEKKKL--NKGGKAALM 170
Cdd:PHA03095  108 ADVNAKDKVGRTPLhvylsgFNI----NPKVIRLLLRKGADVNALdlygmtplavllksRNANVELLRLliDAGADVYAV 183
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 171 DACWGG---HF--------SVVKTLIqEMGADVNICDNEGRNALiHALKDYQRGKsESDVFeigrFLLDHGIDVNCKDEA 239
Cdd:PHA03095  184 DDRFRSllhHHlqsfkpraRIVRELI-RAGCDPAATDMLGNTPL-HSMATGSSCK-RSLVL----PLLIAGISINARNRY 256
                         250       260       270       280       290
                  ....*....|....*....|....*....|....*....|....*....|....*...
gi 2024423680 240 GRTALILAVQRKNTSLVKALLDR-EDINIddADEDGQTALMVAVEKNAYDIAEMLCKK 296
Cdd:PHA03095  257 GQTPLHYAAVFNNPRACRRLIALgADINA--VSSDGNTPLSLMVRNNNGRAVRAALAK 312
Ank_2 pfam12796
Ankyrin repeats (3 copies);
27-119 9.83e-18

Ankyrin repeats (3 copies);


Pssm-ID: 463710 [Multi-domain]  Cd Length: 91  Bit Score: 78.62  E-value: 9.83e-18
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  27 LNDALRYGQREKVLELLENGADVNSKVEFGWTPLHSAVQSGDKEMVQLLLDKGACphARKDNGGTVFIEAAMVGNVEILE 106
Cdd:pfam12796   1 LHLAAKNGNLELVKLLLENGADANLQDKNGRTALHLAAKNGHLEIVKLLLEHADV--NLKDNGRTALHYAARSGHLEIVK 78
                          90
                  ....*....|...
gi 2024423680 107 LLFGCGFNINDSD 119
Cdd:pfam12796  79 LLLEKGADINVKD 91
Ribonuc_2-5A pfam06479
Ribonuclease 2-5A; This domain is a endoribonuclease. Specifically it cleaves an intron from ...
610-695 7.06e-15

Ribonuclease 2-5A; This domain is a endoribonuclease. Specifically it cleaves an intron from Hac1 mRNA in humans, which causes it to be much more efficiently translated.


Pssm-ID: 461930  Cd Length: 127  Bit Score: 71.74  E-value: 7.06e-15
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 610 IPYPNWTKQIDPEILcimsnSSVGKKFIYT-KKITDLLRLIRNLDEH----PN---KRISEITGDYAEYFLKLFPKLTIY 681
Cdd:pfam06479  34 VVGGDWTKKLDKEFV-----DNLGKYRKYDgDSVRDLLRAIRNKKHHyrelPEevkEILGPLPDGFLSYFTSRFPNLLIH 108
                          90
                  ....*....|....*
gi 2024423680 682 VYNRLRQHPRYS-HF 695
Cdd:pfam06479 109 VYKVVKETLKDEdHF 123
PKc cd00180
Catalytic domain of Protein Kinases; PKs catalyze the transfer of the gamma-phosphoryl group ...
375-507 3.36e-09

Catalytic domain of Protein Kinases; PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. PKs make up a large family of serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and more than 500 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase.


Pssm-ID: 270622 [Multi-domain]  Cd Length: 215  Bit Score: 57.67  E-value: 3.36e-09
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 375 SQGDIYLGLY--DGMEVAV-------WIHRRAEGVKEKTFLDQCgSCEHLLKLFQSEQEKGCMYLCFTLWE-KNLEEHLQ 444
Cdd:cd00180     5 SFGKVYKARDkeTGKKVAVkvipkekLKKLLEELLREIEILKKL-NHPNIVKLYDVFETENFLYLVMEYCEgGSLKDLLK 83
                          90       100       110       120       130       140
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 2024423680 445 D---PEDQKDYKGILKMIFQAVRELHSLGFAHQALHPKNFLIDLGGKIYLADFDNTRKLTEGKTEL 507
Cdd:cd00180    84 EnkgPLSEEEALSILRQLLSALEYLHSNGIIHRDLKPENILLDSDGTVKLADFGLAKDLDSDDSLL 149
STKc_CRIK cd05601
Catalytic domain of the Serine/Threonine Kinase, Citron Rho-interacting kinase; STKs catalyze ...
461-577 2.22e-08

Catalytic domain of the Serine/Threonine Kinase, Citron Rho-interacting kinase; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. CRIK (also called citron kinase) is an effector of the small GTPase Rho. It plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. CRIK contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270752 [Multi-domain]  Cd Length: 328  Bit Score: 56.55  E-value: 2.22e-08
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 461 QAVRELHSLGFAHQALHPKNFLIDLGGKIYLADFDNTRKLTEGKT---------------ELINKdLENLSK-------- 517
Cdd:cd05601   113 LAIHSLHSMGYVHRDIKPENILIDRTGHIKLADFGSAAKLSSDKTvtskmpvgtpdyiapEVLTS-MNGGSKgtygvecd 191
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 518 -----LMLYVLTGGKKPLNEVSTEDMAAVSMDH-------------EEALDLIDSLASH-DER-GLEGLSEHPYF----W 573
Cdd:cd05601   192 wwslgIVAYEMLYGKTPFTEDTVIKTYSNIMNFkkflkfpedpkvsESAVDLIKGLLTDaKERlGYEGLCCHPFFsgidW 271

                  ....
gi 2024423680 574 SKQR 577
Cdd:cd05601   272 NNLR 275
S_TKc smart00220
Serine/Threonine protein kinases, catalytic domain; Phosphotransferases. Serine or ...
401-572 3.08e-08

Serine/Threonine protein kinases, catalytic domain; Phosphotransferases. Serine or threonine-specific kinase subfamily.


Pssm-ID: 214567 [Multi-domain]  Cd Length: 254  Bit Score: 55.23  E-value: 3.08e-08
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  401 KEKTFLDQCGsCEHLLKLFQSEQEKGCMYLCFTLWEK-NLEEHLQD----PEDQKdyKGILKMIFQAVRELHSLGFAHQA 475
Cdd:smart00220  46 REIKILKKLK-HPNIVRLYDVFEDEDKLYLVMEYCEGgDLFDLLKKrgrlSEDEA--RFYLRQILSALEYLHSKGIVHRD 122
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  476 LHPKNFLIDLGGKIYLADFDNTRKLTEGKT-------------ELINKdlENLSKL--------MLYVLTGGKKPL---- 530
Cdd:smart00220 123 LKPENILLDEDGHVKLADFGLARQLDPGEKlttfvgtpeymapEVLLG--KGYGKAvdiwslgvILYELLTGKPPFpgdd 200
                          170       180       190       200       210
                   ....*....|....*....|....*....|....*....|....*....|....*..
gi 2024423680  531 ------------NEVSTEDMAAVSmdhEEALDLIDSLASHD--ER-GLEGLSEHPYF 572
Cdd:smart00220 201 qllelfkkigkpKPPFPPPEWDIS---PEAKDLIRKLLVKDpeKRlTAEEALQHPFF 254
Bud32 COG3642
tRNA A-37 threonylcarbamoyl transferase component Bud32 [Translation, ribosomal structure and ...
437-495 1.03e-06

tRNA A-37 threonylcarbamoyl transferase component Bud32 [Translation, ribosomal structure and biogenesis]; tRNA A-37 threonylcarbamoyl transferase component Bud32 is part of the Pathway/BioSystem: tRNA modification


Pssm-ID: 442859 [Multi-domain]  Cd Length: 159  Bit Score: 49.19  E-value: 1.03e-06
                          10        20        30        40        50
                  ....*....|....*....|....*....|....*....|....*....|....*....
gi 2024423680 437 KNLEEHLQDPEDQKDYkgiLKMIFQAVRELHSLGFAHQALHPKNFLIDlGGKIYLADFD 495
Cdd:COG3642    41 ETLADLLEEGELPPEL---LRELGRLLARLHRAGIVHGDLTTSNILVD-DGGVYLIDFG 95
Kdo pfam06293
Lipopolysaccharide kinase (Kdo/WaaP) family; These lipopolysaccharide kinases are related to ...
439-515 9.51e-06

Lipopolysaccharide kinase (Kdo/WaaP) family; These lipopolysaccharide kinases are related to protein kinases pfam00069. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of S. enterica.


Pssm-ID: 428872  Cd Length: 206  Bit Score: 47.00  E-value: 9.51e-06
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 439 LEEHLQDPEDQKD--YKGILKMIFQAVRELHSLGFAHQALHPKNFLIDLGG----KIYLADFDNTRKLTEGkTELINKDL 512
Cdd:pfam06293 104 LADWLADWAVPSGelRRAIWEAVGRLIRQMHRAGVQHGDLYAHHILLQQEGdegfEAWLIDLDKGRLRLPA-RRWRNKDL 182

                  ...
gi 2024423680 513 ENL 515
Cdd:pfam06293 183 ARL 185
ANK smart00248
ankyrin repeats; Ankyrin repeats are about 33 amino acids long and occur in at least four ...
56-84 4.35e-05

ankyrin repeats; Ankyrin repeats are about 33 amino acids long and occur in at least four consecutive copies. They are involved in protein-protein interactions. The core of the repeat seems to be an helix-loop-helix structure.


Pssm-ID: 197603 [Multi-domain]  Cd Length: 30  Bit Score: 40.65  E-value: 4.35e-05
                           10        20
                   ....*....|....*....|....*....
gi 2024423680   56 GWTPLHSAVQSGDKEMVQLLLDKGACPHA 84
Cdd:smart00248   2 GRTPLHLAAENGNLEVVKLLLDKGADINA 30
TRPV5-6 cd22192
Transient Receptor Potential channel, Vanilloid subfamily (TRPV), types 5 and 6; TRPV5 and ...
27-124 4.37e-05

Transient Receptor Potential channel, Vanilloid subfamily (TRPV), types 5 and 6; TRPV5 and TRPV6 (TRPV5/6) are two homologous members within the vanilloid subfamily of the transient receptor potential (TRP) family. TRPV5 and TRPV6 show only 30-40% homology with other members of the TRP family and have unique properties that differentiates them from other TRP channels. They mediate calcium uptake in epithelia and their expression is dramatically increased in numerous types of cancer. The structure of TRPV5/6 shows the typical topology features of all TRP family members, such as six transmembrane regions, a short hydrophobic stretch between transmembrane segments 5 and 6, which is predicted to form the Ca2+ pore, and large intracellular N- and C-terminal domains. The N-terminal domain of TRPV5/6 contains three ankyrin repeats. This structural element is present in several proteins and plays a role in protein-protein interactions. The N- and C-terminal tails of TRPV5/6 each contain an internal PDZ motif which can function as part of a molecular scaffold via interaction with PDZ-domain containing proteins. A major difference between the properties of TRPV5 and TRPV6 is in their tissue distribution: TRPV5 is predominantly expressed in the distal convoluted tubules (DCT) and connecting tubules (CNT) of the kidney, with limited expression in extrarenal tissues. In contrast, TRPV6 has a broader expression pattern such as expression in the intestine, kidney, placenta, epididymis, exocrine tissues, and a few other tissues.


Pssm-ID: 411976 [Multi-domain]  Cd Length: 609  Bit Score: 46.93  E-value: 4.37e-05
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  27 LNDALRYGQREKVLELLENGAD-VN----SKVEFGWTPLHSAVQSGDKEMVQLLLDKGA----------CPHARKDN--- 88
Cdd:cd22192    55 LHVAALYDNLEAAVVLMEAAPElVNepmtSDLYQGETALHIAVVNQNLNLVRELIARGAdvvspratgtFFRPGPKNliy 134
                          90       100       110
                  ....*....|....*....|....*....|....*..
gi 2024423680  89 -GGTVFIEAAMVGNVEILELLFGCGFNINDSDNNGFT 124
Cdd:cd22192   135 yGEHPLSFAACVGNEEIVRLLIEHGADIRAQDSLGNT 171
PLN03224 PLN03224
probable serine/threonine protein kinase; Provisional
446-494 6.52e-05

probable serine/threonine protein kinase; Provisional


Pssm-ID: 178763 [Multi-domain]  Cd Length: 507  Bit Score: 46.22  E-value: 6.52e-05
                          10        20        30        40        50
                  ....*....|....*....|....*....|....*....|....*....|..
gi 2024423680 446 PEDQKDY---KGILKMIFQAVRELHSLGFAHQALHPKNFLIDLGGKIYLADF 494
Cdd:PLN03224  302 PQDKRDInviKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDF 353
PUG smart00580
domain in protein kinases, N-glycanases and other nuclear proteins;
641-681 2.51e-04

domain in protein kinases, N-glycanases and other nuclear proteins;


Pssm-ID: 197798  Cd Length: 57  Bit Score: 39.59  E-value: 2.51e-04
                           10        20        30        40        50
                   ....*....|....*....|....*....|....*....|....*....|
gi 2024423680  641 KITDLLRLIRNLDEHP-----NKRISEITGDYAE----YFLKLFPKLTIY 681
Cdd:smart00580   1 SVRDLLRALRNILHHPreekgNPAIKERLGPVPGgfelYFTVGFPRLLIS 50
trp TIGR00870
transient-receptor-potential calcium channel protein; The Transient Receptor Potential Ca2+ ...
154-299 9.91e-04

transient-receptor-potential calcium channel protein; The Transient Receptor Potential Ca2+ Channel (TRP-CC) Family (TC. 1.A.4)The TRP-CC family has also been called the store-operated calcium channel (SOC) family. The prototypical members include the Drosophila retinal proteinsTRP and TRPL (Montell and Rubin, 1989; Hardie and Minke, 1993). SOC members of the family mediate the entry of extracellular Ca2+ into cells in responseto depletion of intracellular Ca2+ stores (Clapham, 1996) and agonist stimulated production of inositol-1,4,5 trisphosphate (IP3). One member of the TRP-CCfamily, mammalian Htrp3, has been shown to form a tight complex with the IP3 receptor (TC #1.A.3.2.1). This interaction is apparently required for IP3 tostimulate Ca2+ release via Htrp3. The vanilloid receptor subtype 1 (VR1), which is the receptor for capsaicin (the ?hot? ingredient in chili peppers) and servesas a heat-activated ion channel in the pain pathway (Caterina et al., 1997), is also a member of this family. The stretch-inhibitable non-selective cation channel(SIC) is identical to the vanilloid receptor throughout all of its first 700 residues, but it exhibits a different sequence in its last 100 residues. VR1 and SICtransport monovalent cations as well as Ca2+. VR1 is about 10x more permeable to Ca2+ than to monovalent ions. Ca2+ overload probably causes cell deathafter chronic exposure to capsaicin. (McCleskey and Gold, 1999). [Transport and binding proteins, Cations and iron carrying compounds]


Pssm-ID: 273311 [Multi-domain]  Cd Length: 743  Bit Score: 42.38  E-value: 9.91e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 154 ASEEKKKLNKGGKAALmDACWGGHFSVVKTLIQEMGAD-VNICDNEGRNALIHALKdyqrgksESDVFEIGRFLLDHgid 232
Cdd:TIGR00870   7 VPAEESPLSDEEKAFL-PAAERGDLASVYRDLEEPKKLnINCPDRLGRSALFVAAI-------ENENLELTELLLNL--- 75
                          90       100       110       120       130       140       150
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 2024423680 233 vNCKDEAGRTALILAVQRKNTSLVKALL-----DREDINIDDADED-------GQTALMVAVEKNAYDIAEMLCKKGAR 299
Cdd:TIGR00870  76 -SCRGAVGDTLLHAISLEYVDAVEAILLhllaaFRKSGPLELANDQytseftpGITALHLAAHRQNYEIVKLLLERGAS 153
 
Name Accession Description Interval E-value
RNase_RNase-L cd10423
RNase domain (also known as the kinase extension nuclease domain) of RNase L; Ribonuclease L ...
576-687 1.26e-49

RNase domain (also known as the kinase extension nuclease domain) of RNase L; Ribonuclease L (RNase L), sometimes referred to as the 2-5A-dependent RNase, is a highly regulated, latent endoribonuclease (thus the 'L' in RNase L) and is widely expressed in most mammalian tissues. It is involved in the mediation of the antiviral and pro-apoptotic activities of the interferon-inducible 2-5A system, which blocks infections by certain types of viruses through cleavage of viral and cellular single-stranded RNA. RNase L is unique in that it is composed of three major domains; N-terminus regulatory ankyrin repeat domain (ARD), followed by a linker, a protein kinase (PK)-like domain and a C-terminal ribonuclease (RNase) domain. The RNase domain has homology with IRE1, also containing both a kinase and an endoribonuclease, that functions in the unfolded protein response (UPR). RNase L has been shown to have an impact on the pathogenesis of prostate cancer; the RNase L gene, RNASEL, has been identified as a strong candidate for the hereditary prostate cancer 1 (HPC1) allele. The broad range of biological functions of RNase offers a possibility for RNase L as a therapeutic target.


Pssm-ID: 199218  Cd Length: 119  Bit Score: 169.19  E-value: 1.26e-49
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 576 QRKFNTLKNIWNKIKDLTDDDKKDAYNTLNAGEPIP---YPNWTKQIDPEILCIMSNSSVGKKFIYTKKITDLLRLIRNL 652
Cdd:cd10423     1 ENRYRTLRNVGNESDIKTRDDKSDILRLLQAGKSECsrsFPNWTSKIDKEVMDIMNKFYEKKKFFYQDTVGDLLKFIRNL 80
                          90       100       110
                  ....*....|....*....|....*....|....*....
gi 2024423680 653 DEH----PNKRISEITGDYAEYFLKLFPKLTIYVYNRLR 687
Cdd:cd10423    81 GEHideeKNKRMKEIIGDPSEYFQKTFPDLVIYVYKKLR 119
ANKYR COG0666
Ankyrin repeat [Signal transduction mechanisms];
18-307 3.18e-42

Ankyrin repeat [Signal transduction mechanisms];


Pssm-ID: 440430 [Multi-domain]  Cd Length: 289  Bit Score: 155.11  E-value: 3.18e-42
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  18 QRAESIASELNDALRYGQREKVLELLENGADVNSKVEFGWTPLHSAVQSGDKEMVQLLLDKGACPHARKDNGGTVFIEAA 97
Cdd:COG0666    16 LLLLLLALLLLAAALLLLLLLLLLLLLALLALALADALGALLLLAAALAGDLLVALLLLAAGADINAKDDGGNTLLHAAA 95
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  98 MVGNVEILELLFGCGFNINDSDNNGFTAFMEAAWYGKEEALRFLHSKGADVNMRrnaseekkklNKGGKAALMDACWGGH 177
Cdd:COG0666    96 RNGDLEIVKLLLEAGADVNARDKDGETPLHLAAYNGNLEIVKLLLEAGADVNAQ----------DNDGNTPLHLAAANGN 165
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 178 FSVVKTLIqEMGADVNICDNEGRNALIHAlkdyqrgkSESDVFEIGRFLLDHGIDVNCKDEAGRTALILAVQRKNTSLVK 257
Cdd:COG0666   166 LEIVKLLL-EAGADVNARDNDGETPLHLA--------AENGHLEIVKLLLEAGADVNAKDNDGKTALDLAAENGNLEIVK 236
                         250       260       270       280       290
                  ....*....|....*....|....*....|....*....|....*....|
gi 2024423680 258 ALLDREdINIDDADEDGQTALMVAVEKNAYDIAEMLCKKGARADTGKLIA 307
Cdd:COG0666   237 LLLEAG-ADLNAKDKDGLTALLLAAAAGAALIVKLLLLALLLLAAALLDL 285
ANKYR COG0666
Ankyrin repeat [Signal transduction mechanisms];
37-316 5.12e-39

Ankyrin repeat [Signal transduction mechanisms];


Pssm-ID: 440430 [Multi-domain]  Cd Length: 289  Bit Score: 145.87  E-value: 5.12e-39
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  37 EKVLELLENGADVNSKVEFGWTPLHSAVQSGDKEMVQLLLDKGACPHARKDNGGTVFIEAAMVGNVEILELLFGCGFNIN 116
Cdd:COG0666     2 LLLLLLLLLLLAALLLLLLLALLLLAAALLLLLLLLLLLLLALLALALADALGALLLLAAALAGDLLVALLLLAAGADIN 81
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 117 DSDNNGFTAFMEAAWYGKEEALRFLHSKGADVNMRrnaseekkklNKGGKAALMDACWGGHFSVVKTLIqEMGADVNICD 196
Cdd:COG0666    82 AKDDGGNTLLHAAARNGDLEIVKLLLEAGADVNAR----------DKDGETPLHLAAYNGNLEIVKLLL-EAGADVNAQD 150
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 197 NEGRNALIHALkdyQRGKsesdvFEIGRFLLDHGIDVNCKDEAGRTALILAVQRKNTSLVKALLDReDINIDDADEDGQT 276
Cdd:COG0666   151 NDGNTPLHLAA---ANGN-----LEIVKLLLEAGADVNARDNDGETPLHLAAENGHLEIVKLLLEA-GADVNAKDNDGKT 221
                         250       260       270       280
                  ....*....|....*....|....*....|....*....|
gi 2024423680 277 ALMVAVEKNAYDIAEMLCKKGARADTGKLIAVANRNRASE 316
Cdd:COG0666   222 ALDLAAENGNLEIVKLLLEAGADLNAKDKDGLTALLLAAA 261
ANKYR COG0666
Ankyrin repeat [Signal transduction mechanisms];
18-244 3.71e-38

Ankyrin repeat [Signal transduction mechanisms];


Pssm-ID: 440430 [Multi-domain]  Cd Length: 289  Bit Score: 143.56  E-value: 3.71e-38
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  18 QRAESIASELNDALRYGQREKVLELLENGADVNSKVEFGWTPLHSAVQSGDKEMVQLLLDKGACPHARKDNGGTVFIEAA 97
Cdd:COG0666    82 AKDDGGNTLLHAAARNGDLEIVKLLLEAGADVNARDKDGETPLHLAAYNGNLEIVKLLLEAGADVNAQDNDGNTPLHLAA 161
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  98 MVGNVEILELLFGCGFNINDSDNNGFTAFMEAAWYGKEEALRFLHSKGADVNMRrnaseekkklNKGGKAALMDACWGGH 177
Cdd:COG0666   162 ANGNLEIVKLLLEAGADVNARDNDGETPLHLAAENGHLEIVKLLLEAGADVNAK----------DNDGKTALDLAAENGN 231
                         170       180       190       200       210       220
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 2024423680 178 FSVVKTLIqEMGADVNICDNEGRNALIHALKDYQRgksesdvfEIGRFLLDHGIDVNCKDEAGRTAL 244
Cdd:COG0666   232 LEIVKLLL-EAGADLNAKDKDGLTALLLAAAAGAA--------LIVKLLLLALLLLAAALLDLLTLL 289
PHA03095 PHA03095
ankyrin-like protein; Provisional
37-296 7.58e-19

ankyrin-like protein; Provisional


Pssm-ID: 222980 [Multi-domain]  Cd Length: 471  Bit Score: 90.08  E-value: 7.58e-19
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  37 EKVLELLENGADVNSKVEFGWTPLHSAVQSG---DKEMVQLLLDKGACPHARKDNGGTVFIEAAMVGNVE-ILELLFGCG 112
Cdd:PHA03095   28 EEVRRLLAAGADVNFRGEYGKTPLHLYLHYSsekVKDIVRLLLEAGADVNAPERCGFTPLHLYLYNATTLdVIKLLIKAG 107
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 113 FNINDSDNNGFTAF------MEAawygKEEALRFLHSKGADVNMR--------------RNASEEKKKL--NKGGKAALM 170
Cdd:PHA03095  108 ADVNAKDKVGRTPLhvylsgFNI----NPKVIRLLLRKGADVNALdlygmtplavllksRNANVELLRLliDAGADVYAV 183
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 171 DACWGG---HF--------SVVKTLIqEMGADVNICDNEGRNALiHALKDYQRGKsESDVFeigrFLLDHGIDVNCKDEA 239
Cdd:PHA03095  184 DDRFRSllhHHlqsfkpraRIVRELI-RAGCDPAATDMLGNTPL-HSMATGSSCK-RSLVL----PLLIAGISINARNRY 256
                         250       260       270       280       290
                  ....*....|....*....|....*....|....*....|....*....|....*...
gi 2024423680 240 GRTALILAVQRKNTSLVKALLDR-EDINIddADEDGQTALMVAVEKNAYDIAEMLCKK 296
Cdd:PHA03095  257 GQTPLHYAAVFNNPRACRRLIALgADINA--VSSDGNTPLSLMVRNNNGRAVRAALAK 312
PHA03100 PHA03100
ankyrin repeat protein; Provisional
36-272 1.73e-18

ankyrin repeat protein; Provisional


Pssm-ID: 222984 [Multi-domain]  Cd Length: 422  Bit Score: 88.57  E-value: 1.73e-18
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  36 REKVLE-LLENGADVNSKVEFGWTPLHS-----AVQSGDKEMVQLLLDKGACPHARKDNGGTVFIEAAM--VGNVEILEL 107
Cdd:PHA03100   47 NIDVVKiLLDNGADINSSTKNNSTPLHYlsnikYNLTDVKEIVKLLLEYGANVNAPDNNGITPLLYAISkkSNSYSIVEY 126
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 108 LFGCGFNINDSDNNGFTAFMEAAWYGKE--EALRFLHSKGADVNmrrnaseekkKLNKggkaalmdacwgghfsvVKTLI 185
Cdd:PHA03100  127 LLDNGANVNIKNSDGENLLHLYLESNKIdlKILKLLIDKGVDIN----------AKNR-----------------VNYLL 179
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 186 qEMGADVNICDNEGRNALIHAlkdyqrgkSESDVFEIGRFLLDHGIDVNCKDEAGRTALILAVQRKNTSLVKALLDREDi 265
Cdd:PHA03100  180 -SYGVPINIKDVYGFTPLHYA--------VYNNNPEFVKYLLDLGANPNLVNKYGDTPLHIAILNNNKEIFKLLLNNGP- 249

                  ....*..
gi 2024423680 266 NIDDADE 272
Cdd:PHA03100  250 SIKTIIE 256
Ank_2 pfam12796
Ankyrin repeats (3 copies);
27-119 9.83e-18

Ankyrin repeats (3 copies);


Pssm-ID: 463710 [Multi-domain]  Cd Length: 91  Bit Score: 78.62  E-value: 9.83e-18
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  27 LNDALRYGQREKVLELLENGADVNSKVEFGWTPLHSAVQSGDKEMVQLLLDKGACphARKDNGGTVFIEAAMVGNVEILE 106
Cdd:pfam12796   1 LHLAAKNGNLELVKLLLENGADANLQDKNGRTALHLAAKNGHLEIVKLLLEHADV--NLKDNGRTALHYAARSGHLEIVK 78
                          90
                  ....*....|...
gi 2024423680 107 LLFGCGFNINDSD 119
Cdd:pfam12796  79 LLLEKGADINVKD 91
Ank_2 pfam12796
Ankyrin repeats (3 copies);
221-298 1.63e-17

Ankyrin repeats (3 copies);


Pssm-ID: 463710 [Multi-domain]  Cd Length: 91  Bit Score: 77.85  E-value: 1.63e-17
                          10        20        30        40        50        60        70
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 2024423680 221 EIGRFLLDHGIDVNCKDEAGRTALILAVQRKNTSLVKALLDREDINIDDadeDGQTALMVAVEKNAYDIAEMLCKKGA 298
Cdd:pfam12796  11 ELVKLLLENGADANLQDKNGRTALHLAAKNGHLEIVKLLLEHADVNLKD---NGRTALHYAARSGHLEIVKLLLEKGA 85
Ank_2 pfam12796
Ankyrin repeats (3 copies);
60-151 3.24e-16

Ankyrin repeats (3 copies);


Pssm-ID: 463710 [Multi-domain]  Cd Length: 91  Bit Score: 74.38  E-value: 3.24e-16
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  60 LHSAVQSGDKEMVQLLLDKGACPHARKDNGGTVFIEAAMVGNVEILELLfgCGFNINDSDNNGFTAFMEAAWYGKEEALR 139
Cdd:pfam12796   1 LHLAAKNGNLELVKLLLENGADANLQDKNGRTALHLAAKNGHLEIVKLL--LEHADVNLKDNGRTALHYAARSGHLEIVK 78
                          90
                  ....*....|..
gi 2024423680 140 FLHSKGADVNMR 151
Cdd:pfam12796  79 LLLEKGADINVK 90
Ank_2 pfam12796
Ankyrin repeats (3 copies);
169-269 9.01e-16

Ankyrin repeats (3 copies);


Pssm-ID: 463710 [Multi-domain]  Cd Length: 91  Bit Score: 72.84  E-value: 9.01e-16
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 169 LMDACWGGHFSVVKTLIQEmGADVNICDNEGRNALIHALKdyqrgkseSDVFEIGRFLLDHgIDVNCKDEaGRTALILAV 248
Cdd:pfam12796   1 LHLAAKNGNLELVKLLLEN-GADANLQDKNGRTALHLAAK--------NGHLEIVKLLLEH-ADVNLKDN-GRTALHYAA 69
                          90       100
                  ....*....|....*....|..
gi 2024423680 249 QRKNTSLVKALLDRE-DINIDD 269
Cdd:pfam12796  70 RSGHLEIVKLLLEKGaDINVKD 91
Ribonuc_2-5A pfam06479
Ribonuclease 2-5A; This domain is a endoribonuclease. Specifically it cleaves an intron from ...
610-695 7.06e-15

Ribonuclease 2-5A; This domain is a endoribonuclease. Specifically it cleaves an intron from Hac1 mRNA in humans, which causes it to be much more efficiently translated.


Pssm-ID: 461930  Cd Length: 127  Bit Score: 71.74  E-value: 7.06e-15
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 610 IPYPNWTKQIDPEILcimsnSSVGKKFIYT-KKITDLLRLIRNLDEH----PN---KRISEITGDYAEYFLKLFPKLTIY 681
Cdd:pfam06479  34 VVGGDWTKKLDKEFV-----DNLGKYRKYDgDSVRDLLRAIRNKKHHyrelPEevkEILGPLPDGFLSYFTSRFPNLLIH 108
                          90
                  ....*....|....*
gi 2024423680 682 VYNRLRQHPRYS-HF 695
Cdd:pfam06479 109 VYKVVKETLKDEdHF 123
PHA03100 PHA03100
ankyrin repeat protein; Provisional
39-302 8.37e-15

ankyrin repeat protein; Provisional


Pssm-ID: 222984 [Multi-domain]  Cd Length: 422  Bit Score: 77.01  E-value: 8.37e-15
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  39 VLELLENGADVNSKVEFGWTPLHSAVQSGDKEMVQLLLDKGACPHARKDNGGT--VFIEAAMVG---NVEILELLFGCGF 113
Cdd:PHA03100   18 IKYIIMEDDLNDYSYKKPVLPLYLAKEARNIDVVKILLDNGADINSSTKNNSTplHYLSNIKYNltdVKEIVKLLLEYGA 97
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 114 NINDSDNNGFTAfmeaawygkeealrfLHskgadvnmrrNASEEKKklnkggkaalmdacwgGHFSVVKTLIQeMGADVN 193
Cdd:PHA03100   98 NVNAPDNNGITP---------------LL----------YAISKKS----------------NSYSIVEYLLD-NGANVN 135
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 194 ICDNEGRNALIHALkdyqrgKSESDVFEIGRFLLDHGIDVNCK----------------DEAGRTALILAVQRKNTSLVK 257
Cdd:PHA03100  136 IKNSDGENLLHLYL------ESNKIDLKILKLLIDKGVDINAKnrvnyllsygvpinikDVYGFTPLHYAVYNNNPEFVK 209
                         250       260       270       280
                  ....*....|....*....|....*....|....*....|....*
gi 2024423680 258 ALLDrEDINIDDADEDGQTALMVAVEKNAYDIAEMLCKKGARADT 302
Cdd:PHA03100  210 YLLD-LGANPNLVNKYGDTPLHIAILNNNKEIFKLLLNNGPSIKT 253
Ank_2 pfam12796
Ankyrin repeats (3 copies);
93-194 1.84e-14

Ankyrin repeats (3 copies);


Pssm-ID: 463710 [Multi-domain]  Cd Length: 91  Bit Score: 69.37  E-value: 1.84e-14
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  93 FIEAAMVGNVEILELLFGCGFNINDSDNNGFTAFMEAAWYGKEEALRFLHSKgADVNMRRNaseekkklnkgGKAALMDA 172
Cdd:pfam12796   1 LHLAAKNGNLELVKLLLENGADANLQDKNGRTALHLAAKNGHLEIVKLLLEH-ADVNLKDN-----------GRTALHYA 68
                          90       100
                  ....*....|....*....|..
gi 2024423680 173 CWGGHFSVVKTLIqEMGADVNI 194
Cdd:pfam12796  69 ARSGHLEIVKLLL-EKGADINV 89
PHA02875 PHA02875
ankyrin repeat protein; Provisional
26-298 1.86e-12

ankyrin repeat protein; Provisional


Pssm-ID: 165206 [Multi-domain]  Cd Length: 413  Bit Score: 69.63  E-value: 1.86e-12
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  26 ELNDALRYGQREKVLELLENGADVNSKVEFGWTPLHSAVQSGDKEMVQLLLDKGACPHARKDNGGTVFIEAAMVGNVEIL 105
Cdd:PHA02875    5 ALCDAILFGELDIARRLLDIGINPNFEIYDGISPIKLAMKFRDSEAIKLLMKHGAIPDVKYPDIESELHDAVEEGDVKAV 84
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 106 ELLFGCGFNINDS-DNNGFTAFMEAAWYGKEEALRFLHSKGADVNMrrNASEEKKKLnkggkaalmdacwggHFSVvktl 184
Cdd:PHA02875   85 EELLDLGKFADDVfYKDGMTPLHLATILKKLDIMKLLIARGADPDI--PNTDKFSPL---------------HLAV---- 143
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 185 iqeMGADVNICdnegrnalihalkdyqrgksesdvfeigRFLLDHGIDVNCKDEAGRTALILAVQRKNTSLVKALLDrED 264
Cdd:PHA02875  144 ---MMGDIKGI----------------------------ELLIDHKACLDIEDCCGCTPLIIAMAKGDIAICKMLLD-SG 191
                         250       260       270
                  ....*....|....*....|....*....|....*
gi 2024423680 265 INIDDADEDGQTALM-VAVEKNAYDIAEMLCKKGA 298
Cdd:PHA02875  192 ANIDYFGKNGCVAALcYAIENNKIDIVRLFIKRGA 226
PHA03095 PHA03095
ankyrin-like protein; Provisional
117-313 2.47e-11

ankyrin-like protein; Provisional


Pssm-ID: 222980 [Multi-domain]  Cd Length: 471  Bit Score: 66.59  E-value: 2.47e-11
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 117 DSDNNGFTAFMEAAWYG--------KEEALRFLHSKGADVNMRRNAseekkklnkgGKAALmdaCWGGHFS------VVK 182
Cdd:PHA03095    1 DEEDESVDIIMEAALYDyllnasnvTVEEVRRLLAAGADVNFRGEY----------GKTPL---HLYLHYSsekvkdIVR 67
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 183 TLIqEMGADVNICDNEGRNALiHAlkdYQRGKSESDVFeigRFLLDHGIDVNCKDEAGRTAL--ILAVQRKNTSLVKALL 260
Cdd:PHA03095   68 LLL-EAGADVNAPERCGFTPL-HL---YLYNATTLDVI---KLLIKAGADVNAKDKVGRTPLhvYLSGFNINPKVIRLLL 139
                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|....*
gi 2024423680 261 dREDINIDDADEDGQTALMVAVEKNAYDIA--EMLCKKGAradtgKLIAVANRNR 313
Cdd:PHA03095  140 -RKGADVNALDLYGMTPLAVLLKSRNANVEllRLLIDAGA-----DVYAVDDRFR 188
PHA02874 PHA02874
ankyrin repeat protein; Provisional
40-285 5.17e-11

ankyrin repeat protein; Provisional


Pssm-ID: 165205 [Multi-domain]  Cd Length: 434  Bit Score: 65.37  E-value: 5.17e-11
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  40 LELLEN-----GADVNSKVEFGWTPLHSAVQSGDKEMVQLLLDKGACPHARKDNGGTVFIEAAMVGNVEILELLFgcgfn 114
Cdd:PHA02874   14 IEAIEKiiknkGNCINISVDETTTPLIDAIRSGDAKIVELFIKHGADINHINTKIPHPLLTAIKIGAHDIIKLLI----- 88
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 115 indsDNNGFTAFMEAAWYGKEEALRFLHSkGADVNMRrnaseekkklNKGGKAALMDACWGGHFSVVKTLIqEMGADVNI 194
Cdd:PHA02874   89 ----DNGVDTSILPIPCIEKDMIKTILDC-GIDVNIK----------DAELKTFLHYAIKKGDLESIKMLF-EYGADVNI 152
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 195 CDNEGrNALIHAlkdyqrgKSESDVFEIGRFLLDHGIDVNCKDEAGRTALILAVQRKNTSLVKALLDREDiNIDDADEDG 274
Cdd:PHA02874  153 EDDNG-CYPIHI-------AIKHNFFDIIKLLLEKGAYANVKDNNGESPLHNAAEYGDYACIKLLIDHGN-HIMNKCKNG 223
                         250
                  ....*....|.
gi 2024423680 275 QTALMVAVEKN 285
Cdd:PHA02874  224 FTPLHNAIIHN 234
PHA02874 PHA02874
ankyrin repeat protein; Provisional
27-208 5.95e-11

ankyrin repeat protein; Provisional


Pssm-ID: 165205 [Multi-domain]  Cd Length: 434  Bit Score: 64.98  E-value: 5.95e-11
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  27 LNDALRYGQREKVLELLENGADVNSKVEFGWTPLHSAVQSGDKEMVQLLLDKGACPHARKDNGGTVFIEAAMVGNVEILE 106
Cdd:PHA02874  128 LHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLLLEKGAYANVKDNNGESPLHNAAEYGDYACIK 207
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 107 LLFGCGFNINDSDNNGFTAFMEAawygkeealrFLHSKGADVNMRRNASEEKKKLNKGG--KAALMDACwggHFSVVKTL 184
Cdd:PHA02874  208 LLIDHGNHIMNKCKNGFTPLHNA----------IIHNRSAIELLINNASINDQDIDGSTplHHAINPPC---DIDIIDIL 274
                         170       180
                  ....*....|....*....|....
gi 2024423680 185 IQEmGADVNICDNEGRNALIHALK 208
Cdd:PHA02874  275 LYH-KADISIKDNKGENPIDTAFK 297
PHA02874 PHA02874
ankyrin repeat protein; Provisional
21-283 1.36e-10

ankyrin repeat protein; Provisional


Pssm-ID: 165205 [Multi-domain]  Cd Length: 434  Bit Score: 63.83  E-value: 1.36e-10
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  21 ESIASELNDALRYGQREKVLELLENGADVNSKVEFGWTPLHSAVQSGDKEMVQLLLdkgacpharkDNGGTVFIEAAMVG 100
Cdd:PHA02874   33 DETTTPLIDAIRSGDAKIVELFIKHGADINHINTKIPHPLLTAIKIGAHDIIKLLI----------DNGVDTSILPIPCI 102
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 101 NVEILELLFGCGFNINDSDNNGFTAFMEAAWYGKEEALRFLHSKGADVNMRrnaseekkklNKGGKAALMDACWGGHFSV 180
Cdd:PHA02874  103 EKDMIKTILDCGIDVNIKDAELKTFLHYAIKKGDLESIKMLFEYGADVNIE----------DDNGCYPIHIAIKHNFFDI 172
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 181 VKTLIqEMGADVNICDNEGRNALIHALK--DYQRGKsesdvfeigrFLLDHGIDVNCKDEAGRTALILAVQRkNTSLVKA 258
Cdd:PHA02874  173 IKLLL-EKGAYANVKDNNGESPLHNAAEygDYACIK----------LLIDHGNHIMNKCKNGFTPLHNAIIH-NRSAIEL 240
                         250       260
                  ....*....|....*....|....*
gi 2024423680 259 LLDREDINidDADEDGQTALMVAVE 283
Cdd:PHA02874  241 LINNASIN--DQDIDGSTPLHHAIN 263
PHA02874 PHA02874
ankyrin repeat protein; Provisional
35-260 2.02e-10

ankyrin repeat protein; Provisional


Pssm-ID: 165205 [Multi-domain]  Cd Length: 434  Bit Score: 63.44  E-value: 2.02e-10
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  35 QREKVLELLENGADVNSKVEFGWTPLHSAVQSGDKEMVQLLLDKGACPHARKDNGGTVFIEAAMVGNVEILELLFGCGFN 114
Cdd:PHA02874  103 EKDMIKTILDCGIDVNIKDAELKTFLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLLLEKGAY 182
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 115 INDSDNNGFTAFMEAAWYGKEEALRFLHSKGADVNMRRNaseekkklnkGGKAALMDACWGGHfSVVKTLIQEmgADVNI 194
Cdd:PHA02874  183 ANVKDNNGESPLHNAAEYGDYACIKLLIDHGNHIMNKCK----------NGFTPLHNAIIHNR-SAIELLINN--ASIND 249
                         170       180       190       200       210       220
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 2024423680 195 CDNEGRNALIHALKDyqrgKSESDVFEIgrfLLDHGIDVNCKDEAGRTALILAVQRKN-TSLVKALL 260
Cdd:PHA02874  250 QDIDGSTPLHHAINP----PCDIDIIDI---LLYHKADISIKDNKGENPIDTAFKYINkDPVIKDII 309
PHA02875 PHA02875
ankyrin repeat protein; Provisional
23-194 4.21e-10

ankyrin repeat protein; Provisional


Pssm-ID: 165206 [Multi-domain]  Cd Length: 413  Bit Score: 62.32  E-value: 4.21e-10
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  23 IASELNDALRYGQREKVLELLENGADVNSKV-EFGWTPLHSAVQSGDKEMVQLLLDKGACPHARKDNGGTVFIEAAMVGN 101
Cdd:PHA02875   68 IESELHDAVEEGDVKAVEELLDLGKFADDVFyKDGMTPLHLATILKKLDIMKLLIARGADPDIPNTDKFSPLHLAVMMGD 147
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 102 VEILELLFGCGFNINDSDNNGFTAFMEAAWYGKEEALRFLHSKGADVN-MRRNaseekkklnkGGKAALMDACWGGHFSV 180
Cdd:PHA02875  148 IKGIELLIDHKACLDIEDCCGCTPLIIAMAKGDIAICKMLLDSGANIDyFGKN----------GCVAALCYAIENNKIDI 217
                         170
                  ....*....|....
gi 2024423680 181 VKTLIQEmGADVNI 194
Cdd:PHA02875  218 VRLFIKR-GADCNI 230
PHA03100 PHA03100
ankyrin repeat protein; Provisional
42-121 4.34e-10

ankyrin repeat protein; Provisional


Pssm-ID: 222984 [Multi-domain]  Cd Length: 422  Bit Score: 62.38  E-value: 4.34e-10
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  42 LLENGADVNSKVEFGWTPLHSAVQSGDKEMVQLLLDKGACPHARKDNGGTVFIEAAMVGNVEILELLFGCGFNINDSDNN 121
Cdd:PHA03100  178 LLSYGVPINIKDVYGFTPLHYAVYNNNPEFVKYLLDLGANPNLVNKYGDTPLHIAILNNNKEIFKLLLNNGPSIKTIIET 257
RNase_Ire1_like cd10321
RNase domain (also known as the kinase extension nuclease domain) of Ire1 and RNase L; This ...
615-687 5.77e-10

RNase domain (also known as the kinase extension nuclease domain) of Ire1 and RNase L; This RNase domain is found in the multi-functional protein Ire1; Ire1 also contains a type I transmembrane serine/threonine protein kinase (STK) domain, and a Luminal dimerization domain. Ire1 is essential for the endoplasmic reticulum (ER) unfolded protein response (UPR). The UPR is activated when protein misfolding is detected in the ER in order to reduce the synthesis of new proteins and increase the capacity of the ER to cope with the stress. IRE1 acts as an ER stress sensor; IRE1 dimerizes through its N-terminal luminal domain and forms oligomers, promoting trans-autophosphorylation by its cytosolic kinase domain which stimulates its endoribonuclease (RNase) activity and results in the cleavage of its mRNA substrate, Hac1 in yeast and Xbp1 in metazoans, thus promoting a splicing event that enables translation into a transcription factor which activates the UPR. This RNase domain is also found in Ribonuclease L (RNase L), sometimes referred to as the 2-5A-dependent RNase. RNase L is a highly regulated, latent endoribonuclease widely expressed in most mammalian tissues. It is involved in the mediation of the antiviral and pro-apoptotic activities of the interferon-inducible 2-5A system; the interferon (IFN)-inducible 2'-5'-oligoadenylate synthetase (OAS)/RNase L pathway blocks infections by certain types of viruses through cleavage of viral and cellular single-stranded RNA. RNase L has been shown to have an impact on the pathogenesis of prostate cancer; the RNase L gene, RNASEL, has been identified as a strong candidate for the hereditary prostate cancer 1 (HPC1) allele.


Pssm-ID: 199216  Cd Length: 127  Bit Score: 57.42  E-value: 5.77e-10
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 615 WTKQIDPEILCIMSNSsvGKKFIYTKKITDLLRLIRNLDEH----------PNKRISEIT---GDYAEYFLKLFPKLTIY 681
Cdd:cd10321    44 WNTLIDKNLMDDLSNF--VRRTYNYDQVKDLIRCIRNTIQHhkeiknqlpeKNKEILESLksqDSFFNYFESRFPNLLIF 121

                  ....*.
gi 2024423680 682 VYNRLR 687
Cdd:cd10321   122 LYYKFK 127
Ank_4 pfam13637
Ankyrin repeats (many copies);
56-108 7.83e-10

Ankyrin repeats (many copies);


Pssm-ID: 372654 [Multi-domain]  Cd Length: 54  Bit Score: 54.97  E-value: 7.83e-10
                          10        20        30        40        50
                  ....*....|....*....|....*....|....*....|....*....|...
gi 2024423680  56 GWTPLHSAVQSGDKEMVQLLLDKGACPHARKDNGGTVFIEAAMVGNVEILELL 108
Cdd:pfam13637   1 ELTALHAAAASGHLELLRLLLEKGADINAVDGNGETALHFAASNGNVEVLKLL 53
PHA02876 PHA02876
ankyrin repeat protein; Provisional
42-302 2.63e-09

ankyrin repeat protein; Provisional


Pssm-ID: 165207 [Multi-domain]  Cd Length: 682  Bit Score: 60.46  E-value: 2.63e-09
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  42 LLENGADVNSKVEFGWTPLHSAVQSGDKEMVQLLLDKGACPHARKDNGGTVFIEAAMVGNVEILELLFGCGFNINDSDnn 121
Cdd:PHA02876  164 LLEGGADVNAKDIYCITPIHYAAERGNAKMVNLLLSYGADVNIIALDDLSVLECAVDSKNIDTIKAIIDNRSNINKND-- 241
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 122 gfTAFMEAAWYGKEEALRFLHSKGADVN--------------------------MRRNASEEKKKLnKGGKAALMDACWG 175
Cdd:PHA02876  242 --LSLLKAIRNEDLETSLLLYDAGFSVNsiddckntplhhasqapslsrlvpklLERGADVNAKNI-KGETPLYLMAKNG 318
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 176 GHFSVVKTLIQeMGADVNICDNEgRNALIHALKDYQRGKsesdvfEIGRFLLDHGIDVNCKDEAGRTALILAVQRKNTSL 255
Cdd:PHA02876  319 YDTENIRTLIM-LGADVNAADRL-YITPLHQASTLDRNK------DIVITLLELGANVNARDYCDKTPIHYAAVRNNVVI 390
                         250       260       270       280
                  ....*....|....*....|....*....|....*....|....*...
gi 2024423680 256 VKALLDReDINIDDADEDGQTALMVAV-EKNAYDIAEMLCKKGARADT 302
Cdd:PHA02876  391 INTLLDY-GADIEALSQKIGTALHFALcGTNPYMSVKTLIDRGANVNS 437
PKc cd00180
Catalytic domain of Protein Kinases; PKs catalyze the transfer of the gamma-phosphoryl group ...
375-507 3.36e-09

Catalytic domain of Protein Kinases; PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. PKs make up a large family of serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and more than 500 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase.


Pssm-ID: 270622 [Multi-domain]  Cd Length: 215  Bit Score: 57.67  E-value: 3.36e-09
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 375 SQGDIYLGLY--DGMEVAV-------WIHRRAEGVKEKTFLDQCgSCEHLLKLFQSEQEKGCMYLCFTLWE-KNLEEHLQ 444
Cdd:cd00180     5 SFGKVYKARDkeTGKKVAVkvipkekLKKLLEELLREIEILKKL-NHPNIVKLYDVFETENFLYLVMEYCEgGSLKDLLK 83
                          90       100       110       120       130       140
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 2024423680 445 D---PEDQKDYKGILKMIFQAVRELHSLGFAHQALHPKNFLIDLGGKIYLADFDNTRKLTEGKTEL 507
Cdd:cd00180    84 EnkgPLSEEEALSILRQLLSALEYLHSNGIIHRDLKPENILLDSDGTVKLADFGLAKDLDSDDSLL 149
STKc_IRE1 cd13982
Catalytic domain of the Serine/Threonine kinase, Inositol-requiring protein 1; STKs catalyze ...
375-573 2.04e-08

Catalytic domain of the Serine/Threonine kinase, Inositol-requiring protein 1; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. IRE1, also called Endoplasmic reticulum (ER)-to-nucleus signaling protein (or ERN), is an ER-localized type I transmembrane protein with kinase and endoribonuclease domains in the cytoplasmic side. It acts as an ER stress sensor and is the oldest and most conserved component of the unfolded protein response (UPR) in eukaryotes. The UPR is activated when protein misfolding is detected in the ER in order to decrease the synthesis of new proteins and increase the capacity of the ER to cope with the stress. During ER stress, IRE1 dimerizes and forms oligomers, allowing the kinase domain to undergo trans-autophosphorylation. This leads to a conformational change that stimulates its endoribonuclease activity and results in the cleavage of its mRNA substrate, HAC1 in yeast and XBP1 in metazoans, promoting a splicing event that enables translation into a transcription factor which activates the UPR. Mammals contain two IRE1 proteins, IRE1alpha (or ERN1) and IRE1beta (or ERN2). The Ire1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270884 [Multi-domain]  Cd Length: 269  Bit Score: 56.13  E-value: 2.04e-08
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 375 SQGDI-YLGLYDGMEVAVwihrraegvkeKTFLDQC------------GSCEH--LLKLFQSEQEKGCMYLCFTLWEKNL 439
Cdd:cd13982    13 SEGTIvFRGTFDGRPVAV-----------KRLLPEFfdfadrevqllrESDEHpnVIRYFCTEKDRQFLYIALELCAASL 81
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 440 EEHLQDPEDQKD--YKGI--LKMIFQA---VRELHSLGFAHQALHPKNFLIDLG-----GKIYLADFDNTRKLTEGKT-- 505
Cdd:cd13982    82 QDLVESPRESKLflRPGLepVRLLRQIasgLAHLHSLNIVHRDLKPQNILISTPnahgnVRAMISDFGLCKKLDVGRSsf 161
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 506 ---------------ELINKDL-ENLSK---------LMLYVLTGGKKP------------LNEVSTEDMaaVSMDHE-- 546
Cdd:cd13982   162 srrsgvagtsgwiapEMLSGSTkRRQTRavdifslgcVFYYVLSGGSHPfgdklereanilKGKYSLDKL--LSLGEHgp 239
                         250       260       270
                  ....*....|....*....|....*....|
gi 2024423680 547 EALDLIDSLASHDER---GLEGLSEHPYFW 573
Cdd:cd13982   240 EAQDLIERMIDFDPEkrpSAEEVLNHPFFW 269
STKc_CRIK cd05601
Catalytic domain of the Serine/Threonine Kinase, Citron Rho-interacting kinase; STKs catalyze ...
461-577 2.22e-08

Catalytic domain of the Serine/Threonine Kinase, Citron Rho-interacting kinase; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. CRIK (also called citron kinase) is an effector of the small GTPase Rho. It plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. CRIK contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270752 [Multi-domain]  Cd Length: 328  Bit Score: 56.55  E-value: 2.22e-08
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 461 QAVRELHSLGFAHQALHPKNFLIDLGGKIYLADFDNTRKLTEGKT---------------ELINKdLENLSK-------- 517
Cdd:cd05601   113 LAIHSLHSMGYVHRDIKPENILIDRTGHIKLADFGSAAKLSSDKTvtskmpvgtpdyiapEVLTS-MNGGSKgtygvecd 191
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 518 -----LMLYVLTGGKKPLNEVSTEDMAAVSMDH-------------EEALDLIDSLASH-DER-GLEGLSEHPYF----W 573
Cdd:cd05601   192 wwslgIVAYEMLYGKTPFTEDTVIKTYSNIMNFkkflkfpedpkvsESAVDLIKGLLTDaKERlGYEGLCCHPFFsgidW 271

                  ....
gi 2024423680 574 SKQR 577
Cdd:cd05601   272 NNLR 275
S_TKc smart00220
Serine/Threonine protein kinases, catalytic domain; Phosphotransferases. Serine or ...
401-572 3.08e-08

Serine/Threonine protein kinases, catalytic domain; Phosphotransferases. Serine or threonine-specific kinase subfamily.


Pssm-ID: 214567 [Multi-domain]  Cd Length: 254  Bit Score: 55.23  E-value: 3.08e-08
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  401 KEKTFLDQCGsCEHLLKLFQSEQEKGCMYLCFTLWEK-NLEEHLQD----PEDQKdyKGILKMIFQAVRELHSLGFAHQA 475
Cdd:smart00220  46 REIKILKKLK-HPNIVRLYDVFEDEDKLYLVMEYCEGgDLFDLLKKrgrlSEDEA--RFYLRQILSALEYLHSKGIVHRD 122
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  476 LHPKNFLIDLGGKIYLADFDNTRKLTEGKT-------------ELINKdlENLSKL--------MLYVLTGGKKPL---- 530
Cdd:smart00220 123 LKPENILLDEDGHVKLADFGLARQLDPGEKlttfvgtpeymapEVLLG--KGYGKAvdiwslgvILYELLTGKPPFpgdd 200
                          170       180       190       200       210
                   ....*....|....*....|....*....|....*....|....*....|....*..
gi 2024423680  531 ------------NEVSTEDMAAVSmdhEEALDLIDSLASHD--ER-GLEGLSEHPYF 572
Cdd:smart00220 201 qllelfkkigkpKPPFPPPEWDIS---PEAKDLIRKLLVKDpeKRlTAEEALQHPFF 254
PHA02874 PHA02874
ankyrin repeat protein; Provisional
169-301 4.05e-08

ankyrin repeat protein; Provisional


Pssm-ID: 165205 [Multi-domain]  Cd Length: 434  Bit Score: 56.13  E-value: 4.05e-08
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 169 LMDACWGGHFSVVKTLIQEmGADVNICDNEGRNALIHALKDYQR--------GKSESDVF-------EIGRFLLDHGIDV 233
Cdd:PHA02874   39 LIDAIRSGDAKIVELFIKH-GADINHINTKIPHPLLTAIKIGAHdiikllidNGVDTSILpipciekDMIKTILDCGIDV 117
                          90       100       110       120       130       140
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 2024423680 234 NCKDEAGRTALILAVQRKNTSLVKALLD-REDINIDDadEDGQTALMVAVEKNAYDIAEMLCKKGARAD 301
Cdd:PHA02874  118 NIKDAELKTFLHYAIKKGDLESIKMLFEyGADVNIED--DNGCYPIHIAIKHNFFDIIKLLLEKGAYAN 184
Ank_4 pfam13637
Ankyrin repeats (many copies);
29-76 5.76e-08

Ankyrin repeats (many copies);


Pssm-ID: 372654 [Multi-domain]  Cd Length: 54  Bit Score: 49.58  E-value: 5.76e-08
                          10        20        30        40
                  ....*....|....*....|....*....|....*....|....*....
gi 2024423680  29 DALRYGQREKVLE-LLENGADVNSKVEFGWTPLHSAVQSGDKEMVQLLL 76
Cdd:pfam13637   6 HAAAASGHLELLRlLLEKGADINAVDGNGETALHFAASNGNVEVLKLLL 54
Ank_4 pfam13637
Ankyrin repeats (many copies);
89-142 1.33e-07

Ankyrin repeats (many copies);


Pssm-ID: 372654 [Multi-domain]  Cd Length: 54  Bit Score: 48.42  E-value: 1.33e-07
                          10        20        30        40        50
                  ....*....|....*....|....*....|....*....|....*....|....
gi 2024423680  89 GGTVFIEAAMVGNVEILELLFGCGFNINDSDNNGFTAFMEAAWYGKEEALRFLH 142
Cdd:pfam13637   1 ELTALHAAAASGHLELLRLLLEKGADINAVDGNGETALHFAASNGNVEVLKLLL 54
STKc_Sid2p_like cd05600
Catalytic domain of Fungal Sid2p-like Protein Serine/Threonine Kinases; STKs catalyze the ...
459-524 4.52e-07

Catalytic domain of Fungal Sid2p-like Protein Serine/Threonine Kinases; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. The Sid2p-like group is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270751 [Multi-domain]  Cd Length: 386  Bit Score: 52.73  E-value: 4.52e-07
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 2024423680 459 IFQAVRELHSLGFAHQALHPKNFLIDLGGKIYLADFD-NTRKLTEGKTELINKDLENLSKLMLYVLT 524
Cdd:cd05600   120 MFAAISSLHQLGYIHRDLKPENFLIDSSGHIKLTDFGlASGTLSPKKIESMKIRLEEVKNTAFLELT 186
PLN03192 PLN03192
Voltage-dependent potassium channel; Provisional
27-148 5.55e-07

Voltage-dependent potassium channel; Provisional


Pssm-ID: 215625 [Multi-domain]  Cd Length: 823  Bit Score: 52.95  E-value: 5.55e-07
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  27 LNDALRYGQREKVLELLENGADVNSKVEFGWTPLHSAVQSGDKEMVQLL--LDKGACPHArkdnGGTVFIEAAMVGNVEI 104
Cdd:PLN03192  562 LHIAASKGYEDCVLVLLKHACNVHIRDANGNTALWNAISAKHHKIFRILyhFASISDPHA----AGDLLCTAAKRNDLTA 637
                          90       100       110       120
                  ....*....|....*....|....*....|....*....|....
gi 2024423680 105 LELLFGCGFNINDSDNNGFTAFMEAAWYGKEEALRFLHSKGADV 148
Cdd:PLN03192  638 MKELLKQGLNVDSEDHQGATALQVAMAEDHVDMVRLLIMNGADV 681
PHA02878 PHA02878
ankyrin repeat protein; Provisional
103-284 7.27e-07

ankyrin repeat protein; Provisional


Pssm-ID: 222939 [Multi-domain]  Cd Length: 477  Bit Score: 52.19  E-value: 7.27e-07
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 103 EILELLFGCGFNINDSD-NNGFTAFMEAAWYGKEEALRFLHSKGADVNMrrnaseekkkLNKGGKAALMDACWGGHFSVV 181
Cdd:PHA02878  148 EITKLLLSYGADINMKDrHKGNTALHYATENKDQRLTELLLSYGANVNI----------PDKTNNSPLHHAVKHYNKPIV 217
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 182 KTLIQEmGADVNICDNEGRNAL---IHALKDYqrgksesdvfEIGRFLLDHGIDVNCKDEA-GRTALILAVqrKNTSLVK 257
Cdd:PHA02878  218 HILLEN-GASTDARDKCGNTPLhisVGYCKDY----------DILKLLLEHGVDVNAKSYIlGLTALHSSI--KSERKLK 284
                         170       180
                  ....*....|....*....|....*...
gi 2024423680 258 ALLD-REDINIDDADEDgqTALMVAVEK 284
Cdd:PHA02878  285 LLLEyGADINSLNSYKL--TPLSSAVKQ 310
STKc_TTBK cd14017
Catalytic domain of the Serine/Threonine protein kinase, Tau-Tubulin Kinase; STKs catalyze the ...
366-507 8.69e-07

Catalytic domain of the Serine/Threonine protein kinase, Tau-Tubulin Kinase; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. TTBK is a neuron-specific kinase that phosphorylates the microtubule-associated protein tau and promotes its aggregation. Higher vertebrates contain two TTBK proteins, TTBK1 and TTBK2, both of which have been implicated in neurodegeneration. TTBK1 has been linked to Alzheimer's disease (AD) while TTBK2 is associated with spinocerebellar ataxia type 11 (SCA11). Both AD and SCA11 patients show the presence of neurofibrillary tangles in the brain. The Drosophila TTBK homolog, Asator, is an essential protein that localizes to the mitotic spindle during mitosis and may be involved in regulating microtubule dynamics and function. The TTBK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270919 [Multi-domain]  Cd Length: 263  Bit Score: 51.10  E-value: 8.69e-07
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 366 CVSQRIQSASQGDIYLG--LYDGMEVAVwihrRAEGVK--------EKTFLDQCGSCEHLLKLFQSEQEKGCMYLCFTLW 435
Cdd:cd14017     3 KVVKKIGGGGFGEIYKVrdVVDGEEVAM----KVESKSqpkqvlkmEVAVLKKLQGKPHFCRLIGCGRTERYNYIVMTLL 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 436 EKNLEEHLQDPEDQKDYKG-ILKM---IFQAVRELHSLGFAHQALHPKNFLIDLGG----KIYLADFDNTRKLTEGKTEL 507
Cdd:cd14017    79 GPNLAELRRSQPRGKFSVStTLRLgiqILKAIEDIHEVGFLHRDVKPSNFAIGRGPsderTVYILDFGLARQYTNKDGEV 158
STKc_Mnk1 cd14174
Catalytic domain of the Serine/Threonine kinase, Mitogen-activated protein kinase ...
381-495 8.85e-07

Catalytic domain of the Serine/Threonine kinase, Mitogen-activated protein kinase signal-integrating kinase 1; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. MAPK signal-integrating kinases (Mnks) are MAPK-activated protein kinases and is comprised by a group of four proteins, produced by alternative splicing from two genes (Mnk1 and Mnk2). The isoforms of Mnk1 (1a/1b) and Mnk2 (2a/2b) differ at their C-termini, with the a-form having a longer C-terminus containing a MAPK-binding region. All Mnks contain a catalytic kinase domain and a polybasic region at the N-terminus which binds importin and the eukaryotic initiation factor eIF4G. The best characterized Mnk substrate is eIF4G, whose phosphorylation may promote the export of certain mRNAs from the nucleus. Mnk also phosphorylate substrates that bind to AU-rich elements that regulate mRNA stability and translation. Mnks have also been implicated in tyrosine kinase receptor signaling, inflammation, and cell prolieration or survival. The Mnk subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271076 [Multi-domain]  Cd Length: 289  Bit Score: 51.18  E-value: 8.85e-07
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 381 LGLYDGMEVAVWI------HRRAEGVKEKTFLDQCGSCEHLLKLFQSEQEKGCMYLCF-TLWEKNLEEHLQDPE--DQKD 451
Cdd:cd14174    22 VSLQNGKEYAVKIieknagHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFeKLRGGSILAHIQKRKhfNERE 101
                          90       100       110       120
                  ....*....|....*....|....*....|....*....|....*..
gi 2024423680 452 YKGILKMIFQAVRELHSLGFAHQALHPKNFLIDLGGKIY---LADFD 495
Cdd:cd14174   102 ASRVVRDIASALDFLHTKGIAHRDLKPENILCESPDKVSpvkICDFD 148
Bud32 COG3642
tRNA A-37 threonylcarbamoyl transferase component Bud32 [Translation, ribosomal structure and ...
437-495 1.03e-06

tRNA A-37 threonylcarbamoyl transferase component Bud32 [Translation, ribosomal structure and biogenesis]; tRNA A-37 threonylcarbamoyl transferase component Bud32 is part of the Pathway/BioSystem: tRNA modification


Pssm-ID: 442859 [Multi-domain]  Cd Length: 159  Bit Score: 49.19  E-value: 1.03e-06
                          10        20        30        40        50
                  ....*....|....*....|....*....|....*....|....*....|....*....
gi 2024423680 437 KNLEEHLQDPEDQKDYkgiLKMIFQAVRELHSLGFAHQALHPKNFLIDlGGKIYLADFD 495
Cdd:COG3642    41 ETLADLLEEGELPPEL---LRELGRLLARLHRAGIVHGDLTTSNILVD-DGGVYLIDFG 95
PLN03192 PLN03192
Voltage-dependent potassium channel; Provisional
94-260 1.07e-06

Voltage-dependent potassium channel; Provisional


Pssm-ID: 215625 [Multi-domain]  Cd Length: 823  Bit Score: 52.18  E-value: 1.07e-06
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  94 IEAAMVGNVEILELLFGCGFNINDSDNNGFTAFMEAAWYGKEEALRFLHSKGADVNMRrnaseekkklNKGGKAALMDAC 173
Cdd:PLN03192  530 LTVASTGNAALLEELLKAKLDPDIGDSKGRTPLHIAASKGYEDCVLVLLKHACNVHIR----------DANGNTALWNAI 599
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 174 WGGHFSVVKTLIQ-------EMGADVnICDNEGRNALihalkdyqrgksesdvfEIGRFLLDHGIDVNCKDEAGRTALIL 246
Cdd:PLN03192  600 SAKHHKIFRILYHfasisdpHAAGDL-LCTAAKRNDL-----------------TAMKELLKQGLNVDSEDHQGATALQV 661
                         170
                  ....*....|....
gi 2024423680 247 AVQRKNTSLVKALL 260
Cdd:PLN03192  662 AMAEDHVDMVRLLI 675
STKc_PhKG2 cd14181
Catalytic domain of the Serine/Threonine Kinase, Phosphorylase kinase Gamma 2 subunit; STKs ...
396-494 2.59e-06

Catalytic domain of the Serine/Threonine Kinase, Phosphorylase kinase Gamma 2 subunit; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. Phosphorylase kinase (PhK) catalyzes the phosphorylation of inactive phosphorylase b to form the active phosphorylase a. It coordinates hormonal, metabolic, and neuronal signals to initiate the breakdown of glycogen stores, which enables the maintenance of blood-glucose homeostasis during fasting, and is also used as a source of energy for muscle contraction. PhK is one of the largest and most complex protein kinases, composed of a heterotetramer containing four molecules each of four subunit types: one catalytic (gamma) and three regulatory (alpha, beta, and delta). The gamma 2 subunit (PhKG2) is also referred to as the testis/liver gamma isoform. Mutations in its gene cause autosomal-recessive glycogenosis of the liver. The gamma subunit, when isolated, is constitutively active and does not require phosphorylation of the A-loop for activity. The regulatory subunits restrain this kinase activity until signals are received to relieve this inhibition. For example, the kinase is activated in response to hormonal stimulation, after autophosphorylation or phosphorylation by cAMP-dependent kinase of the alpha and beta subunits. The high-affinity binding of ADP to the beta subunit also stimulates kinase activity, whereas calcium relieves inhibition by binding to the delta (calmodulin) subunit. The PhKG2 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271083 [Multi-domain]  Cd Length: 279  Bit Score: 49.58  E-value: 2.59e-06
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 396 RAEGVKEKTFLDQCGSCEHLLKLFQSEQEKGCMYLCFTLWEK-NLEEHLQDPE--DQKDYKGILKMIFQAVRELHSLGFA 472
Cdd:cd14181    59 RSSTLKEIHILRQVSGHPSIITLIDSYESSTFIFLVFDLMRRgELFDYLTEKVtlSEKETRSIMRSLLEAVSYLHANNIV 138
                          90       100
                  ....*....|....*....|..
gi 2024423680 473 HQALHPKNFLIDLGGKIYLADF 494
Cdd:cd14181   139 HRDLKPENILLDDQLHIKLSDF 160
STKc_CDK7 cd07841
Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7; STKs ...
424-494 2.82e-06

Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270833 [Multi-domain]  Cd Length: 298  Bit Score: 49.88  E-value: 2.82e-06
                          10        20        30        40        50        60        70
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 2024423680 424 EKGCMYLCFTLWEKNLEEHLQDPE---DQKDYKGILKMIFQAVRELHSLGFAHQALHPKNFLIDLGGKIYLADF 494
Cdd:cd07841    73 HKSNINLVFEFMETDLEKVIKDKSivlTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADF 146
PLN03192 PLN03192
Voltage-dependent potassium channel; Provisional
41-192 2.92e-06

Voltage-dependent potassium channel; Provisional


Pssm-ID: 215625 [Multi-domain]  Cd Length: 823  Bit Score: 50.64  E-value: 2.92e-06
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  41 ELLENGADVNSKVEFGWTPLHSAVQSGDKEMVQLLLDKGACPHARKDNGGTVFIEAAMVGNVEILELLFGCGfNINDSDN 120
Cdd:PLN03192  543 ELLKAKLDPDIGDSKGRTPLHIAASKGYEDCVLVLLKHACNVHIRDANGNTALWNAISAKHHKIFRILYHFA-SISDPHA 621
                          90       100       110       120       130       140       150
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 2024423680 121 NGfTAFMEAAWYGKEEALRFLHSKGADVNMRrnaseekkklNKGGKAALMDACWGGHFSVVKTLIQEmGADV 192
Cdd:PLN03192  622 AG-DLLCTAAKRNDLTAMKELLKQGLNVDSE----------DHQGATALQVAMAEDHVDMVRLLIMN-GADV 681
PHA02876 PHA02876
ankyrin repeat protein; Provisional
39-249 4.82e-06

ankyrin repeat protein; Provisional


Pssm-ID: 165207 [Multi-domain]  Cd Length: 682  Bit Score: 50.06  E-value: 4.82e-06
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  39 VLELLENGADVNSKVEFGWTPLHSAVQSG-DKEMVQLLLDKGACPHARKDNGGTVFIEAAMVG-NVEILELLFGCGFNIN 116
Cdd:PHA02876  290 VPKLLERGADVNAKNIKGETPLYLMAKNGyDTENIRTLIMLGADVNAADRLYITPLHQASTLDrNKDIVITLLELGANVN 369
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 117 DSDNNGFTAFMEAAWYGKEEALRFLHSKGADVNMRRnaseekkklNKGGKAALMDACWGGHFSVVKTLIqEMGADVNICD 196
Cdd:PHA02876  370 ARDYCDKTPIHYAAVRNNVVIINTLLDYGADIEALS---------QKIGTALHFALCGTNPYMSVKTLI-DRGANVNSKN 439
                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|...
gi 2024423680 197 NEGRNALIHALKDyqrgKSESDVFEIgrfLLDHGIDVNCKDEAGRTALILAVQ 249
Cdd:PHA02876  440 KDLSTPLHYACKK----NCKLDVIEM---LLDNGADVNAINIQNQYPLLIALE 485
Ank_4 pfam13637
Ankyrin repeats (many copies);
220-260 6.97e-06

Ankyrin repeats (many copies);


Pssm-ID: 372654 [Multi-domain]  Cd Length: 54  Bit Score: 43.80  E-value: 6.97e-06
                          10        20        30        40
                  ....*....|....*....|....*....|....*....|.
gi 2024423680 220 FEIGRFLLDHGIDVNCKDEAGRTALILAVQRKNTSLVKALL 260
Cdd:pfam13637  14 LELLRLLLEKGADINAVDGNGETALHFAASNGNVEVLKLLL 54
PTZ00322 PTZ00322
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase; Provisional
42-122 9.10e-06

6-phosphofructo-2-kinase/fructose-2,6-biphosphatase; Provisional


Pssm-ID: 140343 [Multi-domain]  Cd Length: 664  Bit Score: 49.13  E-value: 9.10e-06
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  42 LLENGADVNSKVEFGWTPLHSAVQSGDKEMVQLLLDKGACPHARKDNGGTVFIEAAMVGNVEILELLFGCGFNINDSDNN 121
Cdd:PTZ00322  101 LLTGGADPNCRDYDGRTPLHIACANGHVQVVRVLLEFGADPTLLDKDGKTPLELAEENGFREVVQLLSRHSQCHFELGAN 180

                  .
gi 2024423680 122 G 122
Cdd:PTZ00322  181 A 181
Kdo pfam06293
Lipopolysaccharide kinase (Kdo/WaaP) family; These lipopolysaccharide kinases are related to ...
439-515 9.51e-06

Lipopolysaccharide kinase (Kdo/WaaP) family; These lipopolysaccharide kinases are related to protein kinases pfam00069. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of S. enterica.


Pssm-ID: 428872  Cd Length: 206  Bit Score: 47.00  E-value: 9.51e-06
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 439 LEEHLQDPEDQKD--YKGILKMIFQAVRELHSLGFAHQALHPKNFLIDLGG----KIYLADFDNTRKLTEGkTELINKDL 512
Cdd:pfam06293 104 LADWLADWAVPSGelRRAIWEAVGRLIRQMHRAGVQHGDLYAHHILLQQEGdegfEAWLIDLDKGRLRLPA-RRWRNKDL 182

                  ...
gi 2024423680 513 ENL 515
Cdd:pfam06293 183 ARL 185
STKc_MAK_like cd07830
Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases; STKs ...
413-494 9.75e-06

Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia, suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270824 [Multi-domain]  Cd Length: 283  Bit Score: 47.91  E-value: 9.75e-06
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 413 EHLLKLFQSEQEKGCMYLCFTLWEKNL----EEHLQDPEDQKDYKGILKMIFQAVRELHSLGFAHQALHPKNFLIDLGGK 488
Cdd:cd07830    58 PNIVKLKEVFRENDELYFVFEYMEGNLyqlmKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV 137

                  ....*.
gi 2024423680 489 IYLADF 494
Cdd:cd07830   138 VKIADF 143
Ank pfam00023
Ankyrin repeat; Ankyrins are multifunctional adaptors that link specific proteins to the ...
56-85 1.08e-05

Ankyrin repeat; Ankyrins are multifunctional adaptors that link specific proteins to the membrane-associated, spectrin- actin cytoskeleton. This repeat-domain is a 'membrane-binding' domain of up to 24 repeated units, and it mediates most of the protein's binding activities. Repeats 13-24 are especially active, with known sites of interaction for the Na/K ATPase, Cl/HCO(3) anion exchanger, voltage-gated sodium channel, clathrin heavy chain and L1 family cell adhesion molecules. The ANK repeats are found to form a contiguous spiral stack such that ion transporters like the anion exchanger associate in a large central cavity formed by the ANK repeat spiral, while clathrin and cell adhesion molecules associate with specific regions outside this cavity.


Pssm-ID: 459634 [Multi-domain]  Cd Length: 34  Bit Score: 42.66  E-value: 1.08e-05
                          10        20        30
                  ....*....|....*....|....*....|.
gi 2024423680  56 GWTPLHSAV-QSGDKEMVQLLLDKGACPHAR 85
Cdd:pfam00023   2 GNTPLHLAAgRRGNLEIVKLLLSKGADVNAR 32
STKc_CDKL cd07833
Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases; STKs ...
413-505 1.18e-05

Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270827 [Multi-domain]  Cd Length: 288  Bit Score: 47.70  E-value: 1.18e-05
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 413 EHLLKLFQSEQEKGCMYLCFTLWEKNLEEHLQDPEDQKDYKGILKMIFQ---AVRELHSLGFAHQALHPKNFLIDLGGKI 489
Cdd:cd07833    60 ENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQllqAIAYCHSHNIIHRDIKPENILVSESGVL 139
                          90
                  ....*....|....*.
gi 2024423680 490 YLADFDNTRKLTEGKT 505
Cdd:cd07833   140 KLCDFGFARALTARPA 155
STKc_PhKG cd14093
Catalytic domain of the Serine/Threonine Kinase, Phosphorylase kinase Gamma subunit; STKs ...
396-505 1.31e-05

Catalytic domain of the Serine/Threonine Kinase, Phosphorylase kinase Gamma subunit; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. Phosphorylase kinase (PhK) catalyzes the phosphorylation of inactive phosphorylase b to form the active phosphorylase a. It coordinates hormonal, metabolic, and neuronal signals to initiate the breakdown of glycogen stores, which enables the maintenance of blood-glucose homeostasis during fasting, and is also used as a source of energy for muscle contraction. PhK is one of the largest and most complex protein kinases, composed of a heterotetramer containing four molecules each of four subunit types: one catalytic (gamma) and three regulatory (alpha, beta, and delta). Each subunit has tissue-specific isoforms or splice variants. Vertebrates contain two isoforms of the gamma subunit (gamma 1 and gamma 2). The gamma subunit, when isolated, is constitutively active and does not require phosphorylation of the A-loop for activity. The regulatory subunits restrain this kinase activity until signals are received to relieve this inhibition. For example, the kinase is activated in response to hormonal stimulation, after autophosphorylation or phosphorylation by cAMP-dependent kinase of the alpha and beta subunits. The high-affinity binding of ADP to the beta subunit also stimulates kinase activity, whereas calcium relieves inhibition by binding to the delta (calmodulin) subunit. The PhKG subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270995 [Multi-domain]  Cd Length: 272  Bit Score: 47.35  E-value: 1.31e-05
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 396 RAEGVKEKTFLDQCGSCEHLLKLFQSEQEKGCMYLCFTLWEKN-----LEEHLQDPEdqKDYKGILKMIFQAVRELHSLG 470
Cdd:cd14093    52 REATRREIEILRQVSGHPNIIELHDVFESPTFIFLVFELCRKGelfdyLTEVVTLSE--KKTRRIMRQLFEAVEFLHSLN 129
                          90       100       110
                  ....*....|....*....|....*....|....*
gi 2024423680 471 FAHQALHPKNFLIDLGGKIYLADFDNTRKLTEGKT 505
Cdd:cd14093   130 IVHRDLKPENILLDDNLNVKISDFGFATRLDEGEK 164
STKc_CK1 cd14016
Catalytic domain of the Serine/Threonine protein kinase, Casein Kinase 1; STKs catalyze the ...
369-494 1.32e-05

Catalytic domain of the Serine/Threonine protein kinase, Casein Kinase 1; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. CK1 phosphorylates a variety of substrates including enzymes, transcription and splice factors, cytoskeletal proteins, viral oncogenes, receptors, and membrane-associated proteins. There are mutliple isoforms of CK1 and in mammals, seven isoforms (alpha, beta, gamma1-3, delta, and epsilon) have been characterized. These isoforms differ mainly in the length and structure of their C-terminal non-catalytic region. Some isoforms have several splice variants such as the long (L) and short (S) variants of CK1alpha. CK1 proteins are involved in the regulation of many cellular processes including membrane transport processes, circadian rhythm, cell division, apoptosis, and the development of cancer and neurodegenerative diseases. The CK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270918 [Multi-domain]  Cd Length: 266  Bit Score: 47.45  E-value: 1.32e-05
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 369 QRIQSASQGDIYLG--LYDGMEVAVWIHRRAEGV----KEKTFLDQCGSCEHLLKLFQSEQEKGCMYLCFTLWEKNLEEH 442
Cdd:cd14016     6 KKIGSGSFGEVYLGidLKTGEEVAIKIEKKDSKHpqleYEAKVYKLLQGGPGIPRLYWFGQEGDYNVMVMDLLGPSLEDL 85
                          90       100       110       120       130       140
                  ....*....|....*....|....*....|....*....|....*....|....*....|..
gi 2024423680 443 LQdpedQKDYKGILKMIF-------QAVRELHSLGFAHQALHPKNFLIDLG---GKIYLADF 494
Cdd:cd14016    86 FN----KCGRKFSLKTVLmladqmiSRLEYLHSKGYIHRDIKPENFLMGLGknsNKVYLIDF 143
Ank_4 pfam13637
Ankyrin repeats (many copies);
124-185 1.33e-05

Ankyrin repeats (many copies);


Pssm-ID: 372654 [Multi-domain]  Cd Length: 54  Bit Score: 43.03  E-value: 1.33e-05
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|..
gi 2024423680 124 TAFMEAAWYGKEEALRFLHSKGADVNMRrnaseekkklNKGGKAALMDACWGGHFSVVKTLI 185
Cdd:pfam13637   3 TALHAAAASGHLELLRLLLEKGADINAV----------DGNGETALHFAASNGNVEVLKLLL 54
PHA02878 PHA02878
ankyrin repeat protein; Provisional
59-298 2.55e-05

ankyrin repeat protein; Provisional


Pssm-ID: 222939 [Multi-domain]  Cd Length: 477  Bit Score: 47.18  E-value: 2.55e-05
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  59 PLHSAVQSGDKEMVQLLLDKGACPHaRKDNGGTVFI-----EAAMVGNVEILELLfgcgfnINDSDNNGFTAFMEAAWYG 133
Cdd:PHA02878   40 PLHQAVEARNLDVVKSLLTRGHNVN-QPDHRDLTPLhiickEPNKLGMKEMIRSI------NKCSVFYTLVAIKDAFNNR 112
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 134 KEEALRFLHSKGADvnmrRNASEEKKKLNKGGKAALMDAcwgghfSVVKTLIqEMGADVNICDNEGRNALIHALkdyqrg 213
Cdd:PHA02878  113 NVEIFKIILTNRYK----NIQTIDLVYIDKKSKDDIIEA------EITKLLL-SYGADINMKDRHKGNTALHYA------ 175
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 214 kSESDVFEIGRFLLDHGIDVNCKDEAGRTALILAVQRKNTSLVKALLdREDINIDDADEDGQTALMVAVEK-NAYDIAEM 292
Cdd:PHA02878  176 -TENKDQRLTELLLSYGANVNIPDKTNNSPLHHAVKHYNKPIVHILL-ENGASTDARDKCGNTPLHISVGYcKDYDILKL 253

                  ....*.
gi 2024423680 293 LCKKGA 298
Cdd:PHA02878  254 LLEHGV 259
RIO2 COG0478
RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction ...
443-515 4.33e-05

RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms];


Pssm-ID: 440246 [Multi-domain]  Cd Length: 183  Bit Score: 44.90  E-value: 4.33e-05
                          10        20        30        40        50        60        70
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 2024423680 443 LQDPEDqkdykgILKMIFQAVRELHSLGFAHQALHPKNFLIDLGGKIYLADFDN-TRKLTEGKTELINKDLENL 515
Cdd:COG0478    89 LEDPEE------VLDKILEEIRRAHDAGIVHADLSEYNILVDDDGGVWIIDWPQaVPRDHPNAEELLERDLENL 156
ANK smart00248
ankyrin repeats; Ankyrin repeats are about 33 amino acids long and occur in at least four ...
56-84 4.35e-05

ankyrin repeats; Ankyrin repeats are about 33 amino acids long and occur in at least four consecutive copies. They are involved in protein-protein interactions. The core of the repeat seems to be an helix-loop-helix structure.


Pssm-ID: 197603 [Multi-domain]  Cd Length: 30  Bit Score: 40.65  E-value: 4.35e-05
                           10        20
                   ....*....|....*....|....*....
gi 2024423680   56 GWTPLHSAVQSGDKEMVQLLLDKGACPHA 84
Cdd:smart00248   2 GRTPLHLAAENGNLEVVKLLLDKGADINA 30
TRPV5-6 cd22192
Transient Receptor Potential channel, Vanilloid subfamily (TRPV), types 5 and 6; TRPV5 and ...
27-124 4.37e-05

Transient Receptor Potential channel, Vanilloid subfamily (TRPV), types 5 and 6; TRPV5 and TRPV6 (TRPV5/6) are two homologous members within the vanilloid subfamily of the transient receptor potential (TRP) family. TRPV5 and TRPV6 show only 30-40% homology with other members of the TRP family and have unique properties that differentiates them from other TRP channels. They mediate calcium uptake in epithelia and their expression is dramatically increased in numerous types of cancer. The structure of TRPV5/6 shows the typical topology features of all TRP family members, such as six transmembrane regions, a short hydrophobic stretch between transmembrane segments 5 and 6, which is predicted to form the Ca2+ pore, and large intracellular N- and C-terminal domains. The N-terminal domain of TRPV5/6 contains three ankyrin repeats. This structural element is present in several proteins and plays a role in protein-protein interactions. The N- and C-terminal tails of TRPV5/6 each contain an internal PDZ motif which can function as part of a molecular scaffold via interaction with PDZ-domain containing proteins. A major difference between the properties of TRPV5 and TRPV6 is in their tissue distribution: TRPV5 is predominantly expressed in the distal convoluted tubules (DCT) and connecting tubules (CNT) of the kidney, with limited expression in extrarenal tissues. In contrast, TRPV6 has a broader expression pattern such as expression in the intestine, kidney, placenta, epididymis, exocrine tissues, and a few other tissues.


Pssm-ID: 411976 [Multi-domain]  Cd Length: 609  Bit Score: 46.93  E-value: 4.37e-05
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  27 LNDALRYGQREKVLELLENGAD-VN----SKVEFGWTPLHSAVQSGDKEMVQLLLDKGA----------CPHARKDN--- 88
Cdd:cd22192    55 LHVAALYDNLEAAVVLMEAAPElVNepmtSDLYQGETALHIAVVNQNLNLVRELIARGAdvvspratgtFFRPGPKNliy 134
                          90       100       110
                  ....*....|....*....|....*....|....*..
gi 2024423680  89 -GGTVFIEAAMVGNVEILELLFGCGFNINDSDNNGFT 124
Cdd:cd22192   135 yGEHPLSFAACVGNEEIVRLLIEHGADIRAQDSLGNT 171
Ank_5 pfam13857
Ankyrin repeats (many copies);
184-247 5.60e-05

Ankyrin repeats (many copies);


Pssm-ID: 433530 [Multi-domain]  Cd Length: 56  Bit Score: 41.18  E-value: 5.60e-05
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|....
gi 2024423680 184 LIQEMGADVNICDNEGRNALIHALKdyqRGKSEsdvfeIGRFLLDHGIDVNCKDEAGRTALILA 247
Cdd:pfam13857   1 LLEHGPIDLNRLDGEGYTPLHVAAK---YGALE-----IVRVLLAYGVDLNLKDEEGLTALDLA 56
Ank_5 pfam13857
Ankyrin repeats (many copies);
226-281 5.77e-05

Ankyrin repeats (many copies);


Pssm-ID: 433530 [Multi-domain]  Cd Length: 56  Bit Score: 41.18  E-value: 5.77e-05
                          10        20        30        40        50
                  ....*....|....*....|....*....|....*....|....*....|....*...
gi 2024423680 226 LLDHG-IDVNCKDEAGRTALILAVQRKNTSLVKALLD-REDINIDdaDEDGQTALMVA 281
Cdd:pfam13857   1 LLEHGpIDLNRLDGEGYTPLHVAAKYGALEIVRVLLAyGVDLNLK--DEEGLTALDLA 56
STKc_ROCK_NDR_like cd05573
Catalytic domain of Rho-associated coiled-coil containing protein kinase (ROCK)- and Nuclear ...
459-523 5.96e-05

Catalytic domain of Rho-associated coiled-coil containing protein kinase (ROCK)- and Nuclear Dbf2-Related (NDR)-like Serine/Threonine Kinases; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. The ROCK/NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270725 [Multi-domain]  Cd Length: 350  Bit Score: 45.74  E-value: 5.96e-05
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 2024423680 459 IFQAVRELHSLGFAHQALHPKNFLIDLGGKIYLADFDNTRKLTEGKTELINKDLENLSKLMLYVL 523
Cdd:cd05573   110 LVLALDSLHKLGFIHRDIKPDNILLDADGHIKLADFGLCTKMNKSGDRESYLNDSVNTLFQDNVL 174
STKc_CDKL5 cd07848
Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5; STKs ...
413-503 6.24e-05

Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270838 [Multi-domain]  Cd Length: 287  Bit Score: 45.37  E-value: 6.24e-05
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 413 EHLLKLFQSEQEKGCMYLCFTLWEKNLEEHLQD------PEDQKDYkgILKMIfQAVRELHSLGFAHQALHPKNFLIDLG 486
Cdd:cd07848    60 ENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEmpngvpPEKVRSY--IYQLI-KAIHWCHKNDIVHRDIKPENLLISHN 136
                          90
                  ....*....|....*..
gi 2024423680 487 GKIYLADFDNTRKLTEG 503
Cdd:cd07848   137 DVLKLCDFGFARNLSEG 153
TRPV3 cd22194
Transient Receptor Potential channel, Vanilloid subfamily (TRPV), type 3; TRPV3 is a ...
27-144 6.39e-05

Transient Receptor Potential channel, Vanilloid subfamily (TRPV), type 3; TRPV3 is a temperature-sensitive Transient Receptor Potential (TRP) ion channel that is activated by warm temperatures, synthetic small-molecule chemicals, and natural compounds from plants. TRPV3 function is regulated by physiological factors such as extracellular divalent cations and acidic pH, intracellular adenosine triphosphate, membrane voltage, and arachidonic acid. It is expressed in both neuronal and non-neuronal tissues including epidermal keratinocytes, epithelial cells in the gut, endothelial cells in blood vessels, and neurons in dorsal root ganglia and CNS. TRPV3 null mice have abnormal hair morphogenesis and compromised skin barrier function. It may play roles in inflammatory skin disorders, such as itch and pain sensation. TRPV3 is also expressed by many neuronal and non-neuronal tissues, showing that TRPV3 might play roles in other unknown cellular and physiological functions. TRPV3 belongs to the vanilloid TRP subfamily (TRPV), named after the founding member vanilloid receptor 1 (TRPV1). The structure of TRPV shows the typical topology features of all TRP ion channel family members, such as six transmembrane regions, a short hydrophobic stretch between transmembrane segments 5 and 6 and large intracellular N- and C-terminal domains.


Pssm-ID: 411978 [Multi-domain]  Cd Length: 680  Bit Score: 46.29  E-value: 6.39e-05
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  27 LNDALRYGQREKVLELLENGADVNSKVE--------------FGWTPLHSAVQSGDKEMVQLLLDKGACPHARKDN-GGT 91
Cdd:cd22194   145 LNIAIERRQGDIVKLLIAKGADVNAHAKgvffnpkykhegfyFGETPLALAACTNQPEIVQLLMEKESTDITSQDSrGNT 224
                          90       100       110       120       130       140
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 2024423680  92 VFIEAAMVG------NVEILEL----LFGC-GFNINDSDNN-GFTAFMEAAWYGKEEALRFLHSK 144
Cdd:cd22194   225 VLHALVTVAedsktqNDFVKRMydmiLLKSeNKNLETIRNNeGLTPLQLAAKMGKAEILKYILSR 289
PLN03224 PLN03224
probable serine/threonine protein kinase; Provisional
446-494 6.52e-05

probable serine/threonine protein kinase; Provisional


Pssm-ID: 178763 [Multi-domain]  Cd Length: 507  Bit Score: 46.22  E-value: 6.52e-05
                          10        20        30        40        50
                  ....*....|....*....|....*....|....*....|....*....|..
gi 2024423680 446 PEDQKDY---KGILKMIFQAVRELHSLGFAHQALHPKNFLIDLGGKIYLADF 494
Cdd:PLN03224  302 PQDKRDInviKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDF 353
PTZ00322 PTZ00322
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase; Provisional
224-293 6.95e-05

6-phosphofructo-2-kinase/fructose-2,6-biphosphatase; Provisional


Pssm-ID: 140343 [Multi-domain]  Cd Length: 664  Bit Score: 46.04  E-value: 6.95e-05
                          10        20        30        40        50        60        70
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 2024423680 224 RFLLDHGIDVNCKDEAGRTALILAVQRKNTSLVKALLD-REDINIddADEDGQTALMVAVEKNAYDIAEML 293
Cdd:PTZ00322   99 RILLTGGADPNCRDYDGRTPLHIACANGHVQVVRVLLEfGADPTL--LDKDGKTPLELAEENGFREVVQLL 167
STKc_MAST_like cd05579
Catalytic domain of Microtubule-associated serine/threonine (MAST) kinase-like proteins; STKs ...
401-494 9.33e-05

Catalytic domain of Microtubule-associated serine/threonine (MAST) kinase-like proteins; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This subfamily includes MAST kinases, MAST-like (MASTL) kinases (also called greatwall kinase or Gwl), and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which like in MASTL, also contains an insert relative to MAST kinases. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MASTL/Gwl is involved in the regulation of mitotic entry, mRNA stabilization, and DNA checkpoint recovery. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. The MAST-like kinase subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270731 [Multi-domain]  Cd Length: 272  Bit Score: 44.90  E-value: 9.33e-05
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 401 KEKTFLDQCgSCEHLLKLFQSEQEKGCMYL---------CFTLWEK--NLEEHLQdpedqkdyKGILKMIFQAVRELHSL 469
Cdd:cd05579    42 AERNILSQA-QNPFVVKLYYSFQGKKNLYLvmeylpggdLYSLLENvgALDEDVA--------RIYIAEIVLALEYLHSH 112
                          90       100
                  ....*....|....*....|....*
gi 2024423680 470 GFAHQALHPKNFLIDLGGKIYLADF 494
Cdd:cd05579   113 GIIHRDLKPDNILIDANGHLKLTDF 137
Ank_5 pfam13857
Ankyrin repeats (many copies);
259-298 1.03e-04

Ankyrin repeats (many copies);


Pssm-ID: 433530 [Multi-domain]  Cd Length: 56  Bit Score: 40.41  E-value: 1.03e-04
                          10        20        30        40
                  ....*....|....*....|....*....|....*....|
gi 2024423680 259 LLDREDINIDDADEDGQTALMVAVEKNAYDIAEMLCKKGA 298
Cdd:pfam13857   1 LLEHGPIDLNRLDGEGYTPLHVAAKYGALEIVRVLLAYGV 40
STKc_MRCK_alpha cd05623
Catalytic domain of the Serine/Threonine Kinase, DMPK-related cell division control protein 42 ...
410-572 1.09e-04

Catalytic domain of the Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase (MRCK) alpha; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. MRCK-alpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. The MRCK-alpha subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This alignment model includes the dimerization domain.


Pssm-ID: 270773 [Multi-domain]  Cd Length: 409  Bit Score: 45.01  E-value: 1.09e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 410 GSCEHLLKLFQSEQEKGCMYLC---------FTLWEKnLEEHLqdPEDQKDYkgILKMIFQAVRELHSLGFAHQALHPKN 480
Cdd:cd05623   129 GDSQWITTLHYAFQDDNNLYLVmdyyvggdlLTLLSK-FEDRL--PEDMARF--YLAEMVLAIDSVHQLHYVHRDIKPDN 203
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 481 FLIDLGGKIYLADFDNTRKLTE----------GKTELINKDLENLSK----------------LMLYVLTGGKKPLNEVS 534
Cdd:cd05623   204 ILMDMNGHIRLADFGSCLKLMEdgtvqssvavGTPDYISPEILQAMEdgkgkygpecdwwslgVCMYEMLYGETPFYAES 283
                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|....*..
gi 2024423680 535 TEDMAAVSMDHEE--------------ALDLIDSL-ASHDER----GLEGLSEHPYF 572
Cdd:cd05623   284 LVETYGKIMNHKErfqfptqvtdvsenAKDLIRRLiCSREHRlgqnGIEDFKNHPFF 340
STKc_DMPK_like cd05597
Catalytic domain of Myotonic Dystrophy protein kinase (DMPK)-like Serine/Threonine Kinases; ...
433-505 1.38e-04

Catalytic domain of Myotonic Dystrophy protein kinase (DMPK)-like Serine/Threonine Kinases; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. Three isoforms of MRCK are known, named alpha, beta and gamma. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270748 [Multi-domain]  Cd Length: 331  Bit Score: 44.65  E-value: 1.38e-04
                          10        20        30        40        50        60        70
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 2024423680 433 TLWEKnLEEHLqdPEDQ-KDYkgILKMIFqAVRELHSLGFAHQALHPKNFLIDLGGKIYLADFDNTRKLTEGKT 505
Cdd:cd05597    90 TLLSK-FEDRL--PEEMaRFY--LAEMVL-AIDSIHQLGYVHRDIKPDNVLLDRNGHIRLADFGSCLKLREDGT 157
PHA02878 PHA02878
ankyrin repeat protein; Provisional
27-149 1.39e-04

ankyrin repeat protein; Provisional


Pssm-ID: 222939 [Multi-domain]  Cd Length: 477  Bit Score: 44.87  E-value: 1.39e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  27 LNDALRYGQREKVLELLE----NGADVNSKVEFGWTPLHSAVQSGDKEMVQLLLDKGACPHARKDNGGT-VFIEAAMVGN 101
Cdd:PHA02878  168 GNTALHYATENKDQRLTElllsYGANVNIPDKTNNSPLHHAVKHYNKPIVHILLENGASTDARDKCGNTpLHISVGYCKD 247
                          90       100       110       120
                  ....*....|....*....|....*....|....*....|....*....
gi 2024423680 102 VEILELLFGCGFNIN-DSDNNGFTAFMEAawYGKEEALRFLHSKGADVN 149
Cdd:PHA02878  248 YDILKLLLEHGVDVNaKSYILGLTALHSS--IKSERKLKLLLEYGADIN 294
STKc_CDK1_CdkB_like cd07835
Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases and of ...
417-494 1.40e-04

Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases and of Plant B-type Cyclin-Dependent protein Kinase; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This subfamily is composed of CDK, CDK2, and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270829 [Multi-domain]  Cd Length: 283  Bit Score: 44.20  E-value: 1.40e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 417 KLFQSEQEKGCMYLCFTLWEKNLEEHL-QDPEDQKDYKGILKMIFQAVREL---HSLGFAHQALHPKNFLIDLGGKIYLA 492
Cdd:cd07835    62 RLLDVVHSENKLYLVFEFLDLDLKKYMdSSPLTGLDPPLIKSYLYQLLQGIafcHSHRVLHRDLKPQNLLIDTEGALKLA 141

                  ..
gi 2024423680 493 DF 494
Cdd:cd07835   142 DF 143
PHA02876 PHA02876
ankyrin repeat protein; Provisional
216-353 1.46e-04

ankyrin repeat protein; Provisional


Pssm-ID: 165207 [Multi-domain]  Cd Length: 682  Bit Score: 45.05  E-value: 1.46e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 216 ESDVFEIGRFLLDHGIDVNCKDEAGRTALILAVQRKNTSLVKALLDR-EDINIddADEDGQTALMVAVEKNAYDIAEMLC 294
Cdd:PHA02876  154 QQDELLIAEMLLEGGADVNAKDIYCITPIHYAAERGNAKMVNLLLSYgADVNI--IALDDLSVLECAVDSKNIDTIKAII 231
                          90       100       110       120       130
                  ....*....|....*....|....*....|....*....|....*....|....*....
gi 2024423680 295 KKGARADTGKLiAVANRNRASEMACLLLKYNTEFVPTQRDNWEPKSKRWRHQLQSLHKM 353
Cdd:PHA02876  232 DNRSNINKNDL-SLLKAIRNEDLETSLLLYDAGFSVNSIDDCKNTPLHHASQAPSLSRL 289
RNase_Ire1 cd10422
RNase domain (also known as the kinase extension nuclease domain) of Ire1; The model ...
614-691 1.47e-04

RNase domain (also known as the kinase extension nuclease domain) of Ire1; The model represents the C-terminal endoribonuclease domain of the multi-functional protein Ire1; Ire1 in addition contains a type I transmembrane serine/threonine protein kinase (STK) domain, and a Luminal dimerization domain. Ire1 is essential for the endoplasmic reticulum (ER) unfolded protein response (UPR), which acts as an ER stress sensor and is the oldest and most conserved component of the UPR in eukaryotes. During ER stress, IRE1 dimerizes through its N-terminal luminal domain and forms oligomers, promoting trans-autophosphorylation by its cytosolic kinase domain. This leads to a conformational change that stimulates its endoribonuclease (RNase) activity and results in the cleavage of its mRNA substrate, Hac1 in yeast and Xbp1 in metazoans, thus promoting a splicing event that enables translation into a transcription factor which activates the UPR. This RNase domain is homologous to the RNase domain of RNase L, and possesses a novel fold for a nuclease and appears to be rigid irrespective of the activation state of IRE1. Structural analysis and mutational studies have revealed that an early stage 'phosphoryl-transfer' competent conformation of IRE1 favors face-to-face dimerization of the kinase domains which precedes and is distinct from the RNase 'active' back-to-back conformation. Furthermore, in yeast IRE1, the flavonol quercetin activates the RNase and potentiates activation of the protein kinase by ADP, hinting at the possible existence of endogenous cytoplasmic ligands that may function along with stress signals from ER lumen in order to modulate IRE1 activity, thus identifying IRE1 as a target for development of ATP-competitive inhibitors to modulate the UPR with specific relevance for multiple myeloma.


Pssm-ID: 199217  Cd Length: 129  Bit Score: 42.19  E-value: 1.47e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 614 NWTKQIDPEILcimsnSSVGKKFIY-TKKITDLLRLIRNLDEH-----PN--KRISEITGDYAEYFLKLFPKLTIYVYNR 685
Cdd:cd10422    40 DWREKLDKTFI-----DNLGKYRKYkGSSVRDLLRALRNKKHHyrelpPDvqELLGPLPDGFLRYFTSRFPNLLIHVYRA 114

                  ....*.
gi 2024423680 686 LRQHPR 691
Cdd:cd10422   115 VSDSLK 120
PKc_like cd13968
Catalytic domain of the Protein Kinase superfamily; The PK superfamily contains the large ...
432-494 1.71e-04

Catalytic domain of the Protein Kinase superfamily; The PK superfamily contains the large family of typical PKs that includes serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins, as well as pseudokinases that lack crucial residues for catalytic activity and/or ATP binding. It also includes phosphoinositide 3-kinases (PI3Ks), aminoglycoside 3'-phosphotransferases (APHs), choline kinase (ChoK), Actin-Fragmin Kinase (AFK), and the atypical RIO and Abc1p-like protein kinases. These proteins catalyze the transfer of the gamma-phosphoryl group from ATP to their target substrates; these include serine/threonine/tyrosine residues in proteins for typical or atypical PKs, the 3-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) or its derivatives for PI3Ks, the 4-hydroxyl of PtdIns for PI4Ks, and other small molecule substrates for APH/ChoK and similar proteins such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine.


Pssm-ID: 270870 [Multi-domain]  Cd Length: 136  Bit Score: 42.04  E-value: 1.71e-04
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|...
gi 2024423680 432 FTLWEKNLEEHLqdpeDQKDYKGILKMIFQAVRELHSLGFAHQALHPKNFLIDLGGKIYLADF 494
Cdd:cd13968    77 GTLIAYTQEEEL----DEKDVESIMYQLAECMRLLHSFHLIHRDLNNDNILLSEDGNVKLIDF 135
STKc_PhKG1 cd14182
Catalytic domain of the Serine/Threonine Kinase, Phosphorylase kinase Gamma 1 subunit; STKs ...
396-504 1.76e-04

Catalytic domain of the Serine/Threonine Kinase, Phosphorylase kinase Gamma 1 subunit; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. Phosphorylase kinase (PhK) catalyzes the phosphorylation of inactive phosphorylase b to form the active phosphorylase a. It coordinates hormonal, metabolic, and neuronal signals to initiate the breakdown of glycogen stores, which enables the maintenance of blood-glucose homeostasis during fasting, and is also used as a source of energy for muscle contraction. PhK is one of the largest and most complex protein kinases, composed of a heterotetramer containing four molecules each of four subunit types: one catalytic (gamma) and three regulatory (alpha, beta, and delta). The gamma 1 subunit (PhKG1) is also referred to as the muscle gamma isoform. The gamma subunit, when isolated, is constitutively active and does not require phosphorylation of the A-loop for activity. The regulatory subunits restrain this kinase activity until signals are received to relieve this inhibition. For example, the kinase is activated in response to hormonal stimulation, after autophosphorylation or phosphorylation by cAMP-dependent kinase of the alpha and beta subunits. The high-affinity binding of ADP to the beta subunit also stimulates kinase activity, whereas calcium relieves inhibition by binding to the delta (calmodulin) subunit. The PhKG1 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271084 [Multi-domain]  Cd Length: 276  Bit Score: 44.14  E-value: 1.76e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 396 RAEGVKEKTFLDQCGSCEHLLKLFQSEQEKGCMYLCFTLWEK-NLEEHLQDPE--DQKDYKGILKMIFQAVRELHSLGFA 472
Cdd:cd14182    53 REATLKEIDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKgELFDYLTEKVtlSEKETRKIMRALLEVICALHKLNIV 132
                          90       100       110
                  ....*....|....*....|....*....|..
gi 2024423680 473 HQALHPKNFLIDLGGKIYLADFDNTRKLTEGK 504
Cdd:cd14182   133 HRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 164
PHA02878 PHA02878
ankyrin repeat protein; Provisional
101-301 2.48e-04

ankyrin repeat protein; Provisional


Pssm-ID: 222939 [Multi-domain]  Cd Length: 477  Bit Score: 44.10  E-value: 2.48e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 101 NVEILELLFGCGFNINDSDNNGFT----AFMEAAWYGKEEALRflhskgadVNMRRNASEEKKKLNkggkaalmDACWGG 176
Cdd:PHA02878   49 NLDVVKSLLTRGHNVNQPDHRDLTplhiICKEPNKLGMKEMIR--------SINKCSVFYTLVAIK--------DAFNNR 112
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 177 HFSVVKTLIqemgadVNICDNEGRNALIhalkdYQRGKSESDVFE--IGRFLLDHGIDVNCKDE-AGRTALILAVQRKNT 253
Cdd:PHA02878  113 NVEIFKIIL------TNRYKNIQTIDLV-----YIDKKSKDDIIEaeITKLLLSYGADINMKDRhKGNTALHYATENKDQ 181
                         170       180       190       200
                  ....*....|....*....|....*....|....*....|....*...
gi 2024423680 254 SLVKALLDReDINIDDADEDGQTALMVAVEKNAYDIAEMLCKKGARAD 301
Cdd:PHA02878  182 RLTELLLSY-GANVNIPDKTNNSPLHHAVKHYNKPIVHILLENGASTD 228
PUG smart00580
domain in protein kinases, N-glycanases and other nuclear proteins;
641-681 2.51e-04

domain in protein kinases, N-glycanases and other nuclear proteins;


Pssm-ID: 197798  Cd Length: 57  Bit Score: 39.59  E-value: 2.51e-04
                           10        20        30        40        50
                   ....*....|....*....|....*....|....*....|....*....|
gi 2024423680  641 KITDLLRLIRNLDEHP-----NKRISEITGDYAE----YFLKLFPKLTIY 681
Cdd:smart00580   1 SVRDLLRALRNILHHPreekgNPAIKERLGPVPGgfelYFTVGFPRLLIS 50
Ank_5 pfam13857
Ankyrin repeats (many copies);
161-206 3.39e-04

Ankyrin repeats (many copies);


Pssm-ID: 433530 [Multi-domain]  Cd Length: 56  Bit Score: 38.87  E-value: 3.39e-04
                          10        20        30        40
                  ....*....|....*....|....*....|....*....|....*.
gi 2024423680 161 LNKGGKAALMDACWGGHFSVVKTLIqEMGADVNICDNEGRNALIHA 206
Cdd:pfam13857  12 LDGEGYTPLHVAAKYGALEIVRVLL-AYGVDLNLKDEEGLTALDLA 56
PHA02876 PHA02876
ankyrin repeat protein; Provisional
104-317 4.19e-04

ankyrin repeat protein; Provisional


Pssm-ID: 165207 [Multi-domain]  Cd Length: 682  Bit Score: 43.51  E-value: 4.19e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 104 ILELLFGCGFNINDSDNNGFTAFMEAAWYGKEEALRFLHSKGADVNMrrnaseekkkLNKGGKAALMDACWGGHFSVVKT 183
Cdd:PHA02876  160 IAEMLLEGGADVNAKDIYCITPIHYAAERGNAKMVNLLLSYGADVNI----------IALDDLSVLECAVDSKNIDTIKA 229
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 184 LIQEMGadvNIcdNEGRNALIHALKDYQrgksesdvFEIGRFLLDHGIDVNCKDEAGRTALILAVQRKNTS-LVKALLDR 262
Cdd:PHA02876  230 IIDNRS---NI--NKNDLSLLKAIRNED--------LETSLLLYDAGFSVNSIDDCKNTPLHHASQAPSLSrLVPKLLER 296
                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|....*..
gi 2024423680 263 eDINIDDADEDGQTALMVaVEKNAYDIAEM--LCKKGARADTGKLIAVANRNRASEM 317
Cdd:PHA02876  297 -GADVNAKNIKGETPLYL-MAKNGYDTENIrtLIMLGADVNAADRLYITPLHQASTL 351
Ank_3 pfam13606
Ankyrin repeat; Ankyrins are multifunctional adaptors that link specific proteins to the ...
55-80 4.46e-04

Ankyrin repeat; Ankyrins are multifunctional adaptors that link specific proteins to the membrane-associated, spectrin- actin cytoskeleton. This repeat-domain is a 'membrane-binding' domain of up to 24 repeated units, and it mediates most of the protein's binding activities.


Pssm-ID: 463933 [Multi-domain]  Cd Length: 30  Bit Score: 38.01  E-value: 4.46e-04
                          10        20
                  ....*....|....*....|....*.
gi 2024423680  55 FGWTPLHSAVQSGDKEMVQLLLDKGA 80
Cdd:pfam13606   1 DGNTPLHLAARNGRLEIVKLLLENGA 26
Ank_4 pfam13637
Ankyrin repeats (many copies);
240-293 4.83e-04

Ankyrin repeats (many copies);


Pssm-ID: 372654 [Multi-domain]  Cd Length: 54  Bit Score: 38.41  E-value: 4.83e-04
                          10        20        30        40        50
                  ....*....|....*....|....*....|....*....|....*....|....
gi 2024423680 240 GRTALILAVQRKNTSLVKALLDReDINIDDADEDGQTALMVAVEKNAYDIAEML 293
Cdd:pfam13637   1 ELTALHAAAASGHLELLRLLLEK-GADINAVDGNGETALHFAASNGNVEVLKLL 53
STKc_CAMK cd05117
The catalytic domain of CAMK family Serine/Threonine Kinases; STKs catalyze the transfer of ...
411-505 5.51e-04

The catalytic domain of CAMK family Serine/Threonine Kinases; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. CaMKs are multifunctional calcium and calmodulin (CaM) stimulated STKs involved in cell cycle regulation. There are several types of CaMKs including CaMKI, CaMKII, and CaMKIV. CaMKI proteins are monomeric and they play pivotal roles in the nervous system, including long-term potentiation, dendritic arborization, neurite outgrowth, and the formation of spines, synapses, and axons. CaMKII is a signaling molecule that translates upstream calcium and reactive oxygen species (ROS) signals into downstream responses that play important roles in synaptic function and cardiovascular physiology. CAMKIV is implicated in regulating several transcription factors like CREB, MEF2, and retinoid orphan receptors, as well as in T-cell development and signaling. The CAMK family also consists of other related kinases including the Phosphorylase kinase Gamma subunit (PhKG), the C-terminal kinase domains of Ribosomal S6 kinase (RSK) and Mitogen and stress-activated kinase (MSK), Doublecortin-like kinase (DCKL), and the MAPK-activated protein kinases MK2, MK3, and MK5, among others. The CAMK family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270687 [Multi-domain]  Cd Length: 258  Bit Score: 42.46  E-value: 5.51e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 411 SCEHLLKLFQSEQEKGCMYLCF------TLWEKnLEEHLQDPEDQKdyKGILKMIFQAVRELHSLGFAHQALHPKNFLI- 483
Cdd:cd05117    57 DHPNIVKLYEVFEDDKNLYLVMelctggELFDR-IVKKGSFSEREA--AKIMKQILSAVAYLHSQGIVHRDLKPENILLa 133
                          90       100
                  ....*....|....*....|....
gi 2024423680 484 --DLGGKIYLADFDNTRKLTEGKT 505
Cdd:cd05117   134 skDPDSPIKIIDFGLAKIFEEGEK 157
PHA02946 PHA02946
ankyin-like protein; Provisional
61-301 6.18e-04

ankyin-like protein; Provisional


Pssm-ID: 165256 [Multi-domain]  Cd Length: 446  Bit Score: 42.73  E-value: 6.18e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  61 HSAVQSGDKEMVQLLLDKGACPHARKDNGGTVFIEAAMVGNVEILELLFGCGFNINDSDNNGFTAFMEAAWYGKE--EAL 138
Cdd:PHA02946   44 YCGIKGLDERFVEELLHRGYSPNETDDDGNYPLHIASKINNNRIVAMLLTHGADPNACDKQHKTPLYYLSGTDDEviERI 123
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 139 RFLHSKGADVNmrrNASEEKkklnkgGKAALMdACWGGHFSVVKTlIQEMGADVNICDNEGRNAL-IHALKDYQRGKSES 217
Cdd:PHA02946  124 NLLVQYGAKIN---NSVDEE------GCGPLL-ACTDPSERVFKK-IMSIGFEARIVDKFGKNHIhRHLMSDNPKASTIS 192
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 218 dvfeigrFLLDHGIDVNCKDEAGRTALILAVQR--KNTSLVKALLDREDINIDDADEDGQTALMVAVEKNAYDIAEMLCK 295
Cdd:PHA02946  193 -------WMMKLGISPSKPDHDGNTPLHIVCSKtvKNVDIINLLLPSTDVNKQNKFGDSPLTLLIKTLSPAHLINKLLST 265

                  ....*.
gi 2024423680 296 KGARAD 301
Cdd:PHA02946  266 SNVITD 271
PHA02798 PHA02798
ankyrin-like protein; Provisional
39-283 8.51e-04

ankyrin-like protein; Provisional


Pssm-ID: 222931 [Multi-domain]  Cd Length: 489  Bit Score: 42.51  E-value: 8.51e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  39 VLELLENGADVNSKVEFGWTPLHSAVQSG---DKEMVQLLLDKGACPHARKDNGGT---VFIEAAMVGNVEILELLFGCG 112
Cdd:PHA02798   92 VKILIENGADINKKNSDGETPLYCLLSNGyinNLEILLFMIENGADTTLLDKDGFTmlqVYLQSNHHIDIEIIKLLLEKG 171
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 113 FNINDSDNngftafmeaaWYGKEEalrfLHSKgadvnmrrnaseEKKKLNKggkaalMDAcwgghfSVVKTLIQEmGADV 192
Cdd:PHA02798  172 VDINTHNN----------KEKYDT----LHCY------------FKYNIDR------IDA------DILKLFVDN-GFII 212
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 193 NICDNEGRNALIHALKD--YQRGKSESDVFEigrFLLDHgIDVNCKDEAGRTALILAVQRKNTSLVKALLDRE-DINIdd 269
Cdd:PHA02798  213 NKENKSHKKKFMEYLNSllYDNKRFKKNILD---FIFSY-IDINQVDELGFNPLYYSVSHNNRKIFEYLLQLGgDINI-- 286
                         250
                  ....*....|....
gi 2024423680 270 ADEDGQTALMVAVE 283
Cdd:PHA02798  287 ITELGNTCLFTAFE 300
trp TIGR00870
transient-receptor-potential calcium channel protein; The Transient Receptor Potential Ca2+ ...
154-299 9.91e-04

transient-receptor-potential calcium channel protein; The Transient Receptor Potential Ca2+ Channel (TRP-CC) Family (TC. 1.A.4)The TRP-CC family has also been called the store-operated calcium channel (SOC) family. The prototypical members include the Drosophila retinal proteinsTRP and TRPL (Montell and Rubin, 1989; Hardie and Minke, 1993). SOC members of the family mediate the entry of extracellular Ca2+ into cells in responseto depletion of intracellular Ca2+ stores (Clapham, 1996) and agonist stimulated production of inositol-1,4,5 trisphosphate (IP3). One member of the TRP-CCfamily, mammalian Htrp3, has been shown to form a tight complex with the IP3 receptor (TC #1.A.3.2.1). This interaction is apparently required for IP3 tostimulate Ca2+ release via Htrp3. The vanilloid receptor subtype 1 (VR1), which is the receptor for capsaicin (the ?hot? ingredient in chili peppers) and servesas a heat-activated ion channel in the pain pathway (Caterina et al., 1997), is also a member of this family. The stretch-inhibitable non-selective cation channel(SIC) is identical to the vanilloid receptor throughout all of its first 700 residues, but it exhibits a different sequence in its last 100 residues. VR1 and SICtransport monovalent cations as well as Ca2+. VR1 is about 10x more permeable to Ca2+ than to monovalent ions. Ca2+ overload probably causes cell deathafter chronic exposure to capsaicin. (McCleskey and Gold, 1999). [Transport and binding proteins, Cations and iron carrying compounds]


Pssm-ID: 273311 [Multi-domain]  Cd Length: 743  Bit Score: 42.38  E-value: 9.91e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 154 ASEEKKKLNKGGKAALmDACWGGHFSVVKTLIQEMGAD-VNICDNEGRNALIHALKdyqrgksESDVFEIGRFLLDHgid 232
Cdd:TIGR00870   7 VPAEESPLSDEEKAFL-PAAERGDLASVYRDLEEPKKLnINCPDRLGRSALFVAAI-------ENENLELTELLLNL--- 75
                          90       100       110       120       130       140       150
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 2024423680 233 vNCKDEAGRTALILAVQRKNTSLVKALL-----DREDINIDDADED-------GQTALMVAVEKNAYDIAEMLCKKGAR 299
Cdd:TIGR00870  76 -SCRGAVGDTLLHAISLEYVDAVEAILLhllaaFRKSGPLELANDQytseftpGITALHLAAHRQNYEIVKLLLERGAS 153
STKc_CDK_like cd07829
Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases; STKs ...
424-494 1.05e-03

Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270823 [Multi-domain]  Cd Length: 282  Bit Score: 41.70  E-value: 1.05e-03
                          10        20        30        40        50        60        70
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 2024423680 424 EKGCMYLCFTLWEKNLEEHLQD---PEDQKDYKGILKMIFQAVRELHSLGFAHQALHPKNFLIDLGGKIYLADF 494
Cdd:cd07829    69 TENKLYLVFEYCDQDLKKYLDKrpgPLPPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNLLINRDGVLKLADF 142
PHA02878 PHA02878
ankyrin repeat protein; Provisional
25-85 1.07e-03

ankyrin repeat protein; Provisional


Pssm-ID: 222939 [Multi-domain]  Cd Length: 477  Bit Score: 42.17  E-value: 1.07e-03
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|...
gi 2024423680  25 SELNDALRYgQREKVLE-LLENGADVNSKVEFGWTPLHSAVQS-GDKEMVQLLLDKGACPHAR 85
Cdd:PHA02878  203 SPLHHAVKH-YNKPIVHiLLENGASTDARDKCGNTPLHISVGYcKDYDILKLLLEHGVDVNAK 264
STKc_MAPKKK cd06606
Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase ...
457-512 1.14e-03

Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270783 [Multi-domain]  Cd Length: 258  Bit Score: 41.35  E-value: 1.14e-03
                          10        20        30        40        50
                  ....*....|....*....|....*....|....*....|....*....|....*.
gi 2024423680 457 KMIFQAVRELHSLGFAHQALHPKNFLIDLGGKIYLADFDNTRKLTEGKTELINKDL 512
Cdd:cd06606   106 RQILEGLEYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLAEIATGEGTKSL 161
STKc_NDR_like_fungal cd05629
Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Serine/Threonine Kinases; STKs ...
462-494 1.28e-03

Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Serine/Threonine Kinases; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension.The fungal NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270778 [Multi-domain]  Cd Length: 377  Bit Score: 41.76  E-value: 1.28e-03
                          10        20        30
                  ....*....|....*....|....*....|...
gi 2024423680 462 AVRELHSLGFAHQALHPKNFLIDLGGKIYLADF 494
Cdd:cd05629   113 AIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDF 145
Ank_5 pfam13857
Ankyrin repeats (many copies);
42-96 1.40e-03

Ankyrin repeats (many copies);


Pssm-ID: 433530 [Multi-domain]  Cd Length: 56  Bit Score: 37.33  E-value: 1.40e-03
                          10        20        30        40        50
                  ....*....|....*....|....*....|....*....|....*....|....*.
gi 2024423680  42 LLENG-ADVNSKVEFGWTPLHSAVQSGDKEMVQLLLDKGACPHARKDNGGTVFIEA 96
Cdd:pfam13857   1 LLEHGpIDLNRLDGEGYTPLHVAAKYGALEIVRVLLAYGVDLNLKDEEGLTALDLA 56
STKc_Mos cd13979
Catalytic domain of the Serine/Threonine kinase, Oocyte maturation factor Mos; STKs catalyze ...
365-503 1.40e-03

Catalytic domain of the Serine/Threonine kinase, Oocyte maturation factor Mos; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. Mos (or c-Mos) is a germ-cell specific kinase that plays roles in both the release of primary arrest and the induction of secondary arrest in oocytes. It is expressed towards the end of meiosis I and is quickly degraded upon fertilization. It is a component of the cytostatic factor (CSF), which is responsible for metaphase II arrest. In addition, Mos activates a phoshorylation cascade that leads to the activation of the p34 subunit of MPF (mitosis-promoting factor or maturation promoting factor), a cyclin-dependent kinase that is responsible for the release of primary arrest in meiosis I. The Mos subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270881 [Multi-domain]  Cd Length: 265  Bit Score: 41.22  E-value: 1.40e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 365 QCVSQRIQSASQGDIYLGLYDGMEVAVWIHRRaegVKEKTFLDQCGSCE---------HLLKLFQSEQEKGCMYLCFTLW 435
Cdd:cd13979     5 LRLQEPLGSGGFGSVYKATYKGETVAVKIVRR---RRKNRASRQSFWAElnaarlrheNIVRVLAAETGTDFASLGLIIM 81
                          90       100       110       120       130       140       150
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 2024423680 436 E----KNLEEHLQDPEDQ---KDYKGILKMIFQAVRELHSLGFAHQALHPKNFLIDLGGKIYLADFDNTRKLTEG 503
Cdd:cd13979    82 EycgnGTLQQLIYEGSEPlplAHRILISLDIARALRFCHSHGIVHLDVKPANILISEQGVCKLCDFGCSVKLGEG 156
STKc_Mnk cd14090
Catalytic domain of the Serine/Threonine kinases, Mitogen-activated protein kinase ...
380-495 1.55e-03

Catalytic domain of the Serine/Threonine kinases, Mitogen-activated protein kinase signal-integrating kinases; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. MAPK signal-integrating kinases (Mnks) are MAPK-activated protein kinases and is comprised by a group of four proteins, produced by alternative splicing from two genes (Mnk1 and Mnk2). The isoforms of Mnk1 (1a/1b) and Mnk2 (2a/2b) differ at their C-termini, with the a-form having a longer C-terminus containing a MAPK-binding region. All Mnks contain a catalytic kinase domain and a polybasic region at the N-terminus which binds importin and the eukaryotic initiation factor eIF4G. The best characterized Mnk substrate is eIF4G, whose phosphorylation may promote the export of certain mRNAs from the nucleus. Mnk also phosphorylate substrates that bind to AU-rich elements that regulate mRNA stability and translation. Mnks have also been implicated in tyrosine kinase receptor signaling, inflammation, and cell prolieration or survival. The Mnk subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270992 [Multi-domain]  Cd Length: 289  Bit Score: 41.25  E-value: 1.55e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 380 YLGLYDGMEVAVWI------HRRAEGVKEKTFLDQCGSCEHLLKLFQSEQEKGCMYLCFtlwEK----NLEEHLQDPE-- 447
Cdd:cd14090    21 CINLYTGKEYAVKIiekhpgHSRSRVFREVETLHQCQGHPNILQLIEYFEDDERFYLVF---EKmrggPLLSHIEKRVhf 97
                          90       100       110       120       130
                  ....*....|....*....|....*....|....*....|....*....|.
gi 2024423680 448 DQKDYKGILKMIFQAVRELHSLGFAHQALHPKNFLIDLGGKIY---LADFD 495
Cdd:cd14090    98 TEQEASLVVRDIASALDFLHDKGIAHRDLKPENILCESMDKVSpvkICDFD 148
PHA03100 PHA03100
ankyrin repeat protein; Provisional
27-128 1.56e-03

ankyrin repeat protein; Provisional


Pssm-ID: 222984 [Multi-domain]  Cd Length: 422  Bit Score: 41.57  E-value: 1.56e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  27 LNDALRYGQREKVLELLENGADVNSKVEFGWTPLHSAVQSGDKEMVQLLLDKGA-----CPHARKDNG---GTVfIEAAM 98
Cdd:PHA03100  196 LHYAVYNNNPEFVKYLLDLGANPNLVNKYGDTPLHIAILNNNKEIFKLLLNNGPsiktiIETLLYFKDkdlNTI-TKIKM 274
                          90       100       110
                  ....*....|....*....|....*....|
gi 2024423680  99 VGNVEILELLFGCGFNINDSDNNGFTAFME 128
Cdd:PHA03100  275 LKKSIMYMFLLDPGFYKNRKLIENSKSLKD 304
STKc_PSKH1 cd14087
Catalytic domain of the Protein Serine/Threonine kinase H1; STKs catalyze the transfer of the ...
449-512 1.66e-03

Catalytic domain of the Protein Serine/Threonine kinase H1; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. PSKH1 is an autophosphorylating STK that is expressed ubiquitously and exhibits multiple intracellular localizations including the centrosome, Golgi apparatus, and splice factor compartments. It contains a catalytic kinase domain and an N-terminal SH4-like motif that is acylated to facilitate membrane attachment. PSKH1 plays a rile in the maintenance of the Golgi apparatus, an important organelle within the secretory pathway. It may also function as a novel splice factor and a regulator of prostate cancer cell growth. The PSKH1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270989 [Multi-domain]  Cd Length: 259  Bit Score: 40.98  E-value: 1.66e-03
                          10        20        30        40        50        60        70
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 2024423680 449 QKDYKGILKMIFQAVRELHSLGFAHQALHPKNFLIDLGG---KIYLADF----------DNTRKLTEGKTELINKDL 512
Cdd:cd14087    96 ERDATRVLQMVLDGVKYLHGLGITHRDLKPENLLYYHPGpdsKIMITDFglastrkkgpNCLMKTTCGTPEYIAPEI 172
STKc_MAPK15-like cd07852
Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 and ...
402-512 1.68e-03

Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 and similar MAPKs; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. MAPKs are important mediators of cellular responses to extracellular signals. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270841 [Multi-domain]  Cd Length: 337  Bit Score: 41.00  E-value: 1.68e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 402 EKTFLDQCGSCEHLLKL---FQSEQEKGcMYLCFTLWEKNLeeH-------LQDpeDQKDYkgILKMIFQAVRELHSLGF 471
Cdd:cd07852    56 EIMFLQELNDHPNIIKLlnvIRAENDKD-IYLVFEYMETDL--HaviraniLED--IHKQY--IMYQLLKALKYLHSGGV 128
                          90       100       110       120
                  ....*....|....*....|....*....|....*....|.
gi 2024423680 472 AHQALHPKNFLIDLGGKIYLADFDNTRKLTEGKTELINKDL 512
Cdd:cd07852   129 IHRDLKPSNILLNSDCRVKLADFGLARSLSQLEEDDENPVL 169
PHA02859 PHA02859
ankyrin repeat protein; Provisional
32-149 1.76e-03

ankyrin repeat protein; Provisional


Pssm-ID: 165195 [Multi-domain]  Cd Length: 209  Bit Score: 40.19  E-value: 1.76e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  32 RYGQREKVLELLENGADVNSKV-EFGWTPLHSAV---QSGDKEMVQLLLDKGACPHARKDNGGT---VFIEAAMVgNVEI 104
Cdd:PHA02859   62 DKVNVEILKFLIENGADVNFKTrDNNLSALHHYLsfnKNVEPEILKILIDSGSSITEEDEDGKNllhMYMCNFNV-RINV 140
                          90       100       110       120
                  ....*....|....*....|....*....|....*....|....*....
gi 2024423680 105 LELLF--GCGFNINDSDNNG--FTAFMeaaWYGKEEALRFLHSKGADVN 149
Cdd:PHA02859  141 IKLLIdsGVSFLNKDFDNNNilYSYIL---FHSDKKIFDFLTSLGIDIN 186
STKc_CaMKI_alpha cd14167
Catalytic domain of the Serine/Threonine kinase, Calcium/calmodulin-dependent protein kinase ...
449-494 1.78e-03

Catalytic domain of the Serine/Threonine kinase, Calcium/calmodulin-dependent protein kinase Type I alpha; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. CaMKs are multifunctional calcium and calmodulin (CaM) stimulated STKs involved in cell cycle regulation. The CaMK family includes CaMKI, CaMKII, CaMKIV, and CaMK kinase (CaMKK). In vertebrates, there are four CaMKI proteins encoded by different genes (alpha, beta, gamma, and delta), each producing at least one variant. CaMKs contain an N-terminal catalytic domain and a C-terminal regulatory domain that harbors a CaM binding site. CaMKI proteins are monomeric and they play pivotal roles in the nervous system, including long-term potentiation, dendritic arborization, neurite outgrowth, and the formation of spines, synapses, and axons. In addition, they may be involved in osteoclast differentiation and bone resorption. The CaMKI-alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271069 [Multi-domain]  Cd Length: 263  Bit Score: 40.78  E-value: 1.78e-03
                          10        20        30        40
                  ....*....|....*....|....*....|....*....|....*....
gi 2024423680 449 QKDYKGILKMIFQAVRELHSLGFAHQALHPKNFL---IDLGGKIYLADF 494
Cdd:cd14167   100 ERDASKLIFQILDAVKYLHDMGIVHRDLKPENLLyysLDEDSKIMISDF 148
Ank_5 pfam13857
Ankyrin repeats (many copies);
114-153 1.79e-03

Ankyrin repeats (many copies);


Pssm-ID: 433530 [Multi-domain]  Cd Length: 56  Bit Score: 36.94  E-value: 1.79e-03
                          10        20        30        40
                  ....*....|....*....|....*....|....*....|
gi 2024423680 114 NINDSDNNGFTAFMEAAWYGKEEALRFLHSKGADVNMRRN 153
Cdd:pfam13857   8 DLNRLDGEGYTPLHVAAKYGALEIVRVLLAYGVDLNLKDE 47
PHA02736 PHA02736
Viral ankyrin protein; Provisional
224-301 1.93e-03

Viral ankyrin protein; Provisional


Pssm-ID: 165103 [Multi-domain]  Cd Length: 154  Bit Score: 39.47  E-value: 1.93e-03
                          10        20        30        40        50        60        70
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 2024423680 224 RFLLDHGIDVNCKDEA-GRTALILAVQRKNTSLVKALLDREDINIDDADEDGQTALMVAVEKNAYDIAEMLCKKGARAD 301
Cdd:PHA02736   75 KLLMEWGADINGKERVfGNTPLHIAVYTQNYELATWLCNQPGVNMEILNYAFKTPYYVACERHDAKMMNILRAKGAQCK 153
STKc_LATS2 cd05626
Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2; STKs ...
462-494 1.93e-03

Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. The LATS2 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 173715 [Multi-domain]  Cd Length: 381  Bit Score: 41.15  E-value: 1.93e-03
                          10        20        30
                  ....*....|....*....|....*....|...
gi 2024423680 462 AVRELHSLGFAHQALHPKNFLIDLGGKIYLADF 494
Cdd:cd05626   113 AIESVHKMGFIHRDIKPDNILIDLDGHIKLTDF 145
SPS1 COG0515
Serine/threonine protein kinase [Signal transduction mechanisms];
413-494 1.98e-03

Serine/threonine protein kinase [Signal transduction mechanisms];


Pssm-ID: 440281 [Multi-domain]  Cd Length: 482  Bit Score: 41.15  E-value: 1.98e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 413 EHLLKLFQSEQEKGCMYLCFTLWE-KNLEEHLQD----PEDQkdykgILKMIFQ---AVRELHSLGFAHQALHPKNFLID 484
Cdd:COG0515    67 PNIVRVYDVGEEDGRPYLVMEYVEgESLADLLRRrgplPPAE-----ALRILAQlaeALAAAHAAGIVHRDIKPANILLT 141
                          90
                  ....*....|
gi 2024423680 485 LGGKIYLADF 494
Cdd:COG0515   142 PDGRVKLIDF 151
STKc_CDK1_euk cd07861
Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher ...
428-494 2.09e-03

Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis as well as neuronal apoptosis in neurodegenerative diseases. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270845 [Multi-domain]  Cd Length: 285  Bit Score: 40.87  E-value: 2.09e-03
                          10        20        30        40        50        60        70
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 2024423680 428 MYLCFTLWEKNLEEHLQ--------DPEDQKDYkgiLKMIFQAVRELHSLGFAHQALHPKNFLIDLGGKIYLADF 494
Cdd:cd07861    74 LYLVFEFLSMDLKKYLDslpkgkymDAELVKSY---LYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADF 145
STKc_MELK cd14078
Catalytic domain of the Serine/Threonine Kinase, Maternal Embryonic Leucine zipper Kinase; ...
453-494 2.27e-03

Catalytic domain of the Serine/Threonine Kinase, Maternal Embryonic Leucine zipper Kinase; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. MELK is a cell cycle dependent protein which functions in cytokinesis, cell cycle, apoptosis, cell proliferation, and mRNA processing. It is found upregulated in many types of cancer cells, playing an indispensable role in cancer cell survival. It makes an attractive target in the design of inhibitors for use in the treatment of a wide range of human cancer. The MELK subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270980 [Multi-domain]  Cd Length: 257  Bit Score: 40.44  E-value: 2.27e-03
                          10        20        30        40
                  ....*....|....*....|....*....|....*....|..
gi 2024423680 453 KGILKMIFQAVRELHSLGFAHQALHPKNFLIDLGGKIYLADF 494
Cdd:cd14078   104 RVFFRQIVSAVAYVHSQGYAHRDLKPENLLLDEDQNLKLIDF 145
STKc_CDK6 cd07862
Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6; STKs ...
400-498 2.54e-03

Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270846 [Multi-domain]  Cd Length: 290  Bit Score: 40.40  E-value: 2.54e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 400 VKEKTFLDQCGSCEH--LLKLF------QSEQEKGcMYLCFTLWEKNLEEHLQD-------PEDQKDykgILKMIFQAVR 464
Cdd:cd07862    49 IREVAVLRHLETFEHpnVVRLFdvctvsRTDRETK-LTLVFEHVDQDLTTYLDKvpepgvpTETIKD---MMFQLLRGLD 124
                          90       100       110
                  ....*....|....*....|....*....|....
gi 2024423680 465 ELHSLGFAHQALHPKNFLIDLGGKIYLADFDNTR 498
Cdd:cd07862   125 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158
TRPV5-6 cd22192
Transient Receptor Potential channel, Vanilloid subfamily (TRPV), types 5 and 6; TRPV5 and ...
215-298 2.62e-03

Transient Receptor Potential channel, Vanilloid subfamily (TRPV), types 5 and 6; TRPV5 and TRPV6 (TRPV5/6) are two homologous members within the vanilloid subfamily of the transient receptor potential (TRP) family. TRPV5 and TRPV6 show only 30-40% homology with other members of the TRP family and have unique properties that differentiates them from other TRP channels. They mediate calcium uptake in epithelia and their expression is dramatically increased in numerous types of cancer. The structure of TRPV5/6 shows the typical topology features of all TRP family members, such as six transmembrane regions, a short hydrophobic stretch between transmembrane segments 5 and 6, which is predicted to form the Ca2+ pore, and large intracellular N- and C-terminal domains. The N-terminal domain of TRPV5/6 contains three ankyrin repeats. This structural element is present in several proteins and plays a role in protein-protein interactions. The N- and C-terminal tails of TRPV5/6 each contain an internal PDZ motif which can function as part of a molecular scaffold via interaction with PDZ-domain containing proteins. A major difference between the properties of TRPV5 and TRPV6 is in their tissue distribution: TRPV5 is predominantly expressed in the distal convoluted tubules (DCT) and connecting tubules (CNT) of the kidney, with limited expression in extrarenal tissues. In contrast, TRPV6 has a broader expression pattern such as expression in the intestine, kidney, placenta, epididymis, exocrine tissues, and a few other tissues.


Pssm-ID: 411976 [Multi-domain]  Cd Length: 609  Bit Score: 41.15  E-value: 2.62e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 215 SESDVFEIGRFLLDHGIDVNCKDEAGRTALILAVQRKNTSLVKALLD--REDINIDDADE--DGQTALMVAVEKNAYDIA 290
Cdd:cd22192    26 KENDVQAIKKLLKCPSCDLFQRGALGETALHVAALYDNLEAAVVLMEaaPELVNEPMTSDlyQGETALHIAVVNQNLNLV 105

                  ....*...
gi 2024423680 291 EMLCKKGA 298
Cdd:cd22192   106 RELIARGA 113
PKc_Myt1 cd14050
Catalytic domain of the Dual-specificity protein kinase, Myt1; Dual-specificity PKs catalyze ...
394-494 2.81e-03

Catalytic domain of the Dual-specificity protein kinase, Myt1; Dual-specificity PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine as well as tyrosine residues on protein substrates. Myt1 is a cytoplasmic cell cycle checkpoint kinase that can keep the cyclin-dependent kinase CDK1 in an inactive state through phosphorylation of N-terminal thr (T14) and tyr (Y15) residues, leading to the delay of meiosis I entry. Meiotic progression is ensured by a two-step inhibition and downregulation of Myt1 by CDK1/XRINGO and p90Rsk during oocyte maturation. In addition, Myt1 targets cyclin B1/B2 and is essential for Golgi and ER assembly during telophase. In Drosophila, Myt1 may be a downstream target of Notch during eye development. The Myt1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine PKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270952 [Multi-domain]  Cd Length: 249  Bit Score: 39.98  E-value: 2.81e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 394 HRRAEGVKEKTFLDQCGSCEHLLKLFQSEQEKGCMY----LCFTLWEKNLEEHLQDPEDQkdYKGILKMIFQAVRELHSL 469
Cdd:cd14050    42 KDRKRKLEEVERHEKLGEHPNCVRFIKAWEEKGILYiqteLCDTSLQQYCEETHSLPESE--VWNILLDLLKGLKHLHDH 119
                          90       100
                  ....*....|....*....|....*
gi 2024423680 470 GFAHQALHPKNFLIDLGGKIYLADF 494
Cdd:cd14050   120 GLIHLDIKPANIFLSKDGVCKLGDF 144
PTKc_Wee1_fungi cd14052
Catalytic domain of the Protein Tyrosine Kinases, Fungal Wee1 proteins; PTKs catalyze the ...
412-494 2.92e-03

Catalytic domain of the Protein Tyrosine Kinases, Fungal Wee1 proteins; PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. This subfamily is composed of fungal Wee1 proteins, also called Swe1 in budding yeast and Mik1 in fission yeast. Yeast Wee1 is required to control cell size. Wee1 is a cell cycle checkpoint kinase that helps keep the cyclin-dependent kinase CDK1 in an inactive state through phosphorylation of an N-terminal tyr (Y15) residue. During the late G2 phase, CDK1 is activated and mitotic entry is promoted by the removal of this inhibitory phosphorylation by the phosphatase Cdc25. Although Wee1 is functionally a tyr kinase, it is more closely related to serine/threonine kinases (STKs). It contains a catalytic kinase domain sandwiched in between N- and C-terminal regulatory domains. It is regulated by phosphorylation and degradation, and its expression levels are also controlled by circadian clock proteins. The fungal Wee1 subfamily is part of a larger superfamily that includes the catalytic domains of STKs, other PTKs, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270954 [Multi-domain]  Cd Length: 278  Bit Score: 40.10  E-value: 2.92e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 412 CEHLLKLFQSEQEKGCMYLCFTLWEK-NLEEHLQDPEDQK--DYKGILKMIFQ---AVRELHSLGFAHQALHPKNFLIDL 485
Cdd:cd14052    62 HDNIVQLIDSWEYHGHLYIQTELCENgSLDVFLSELGLLGrlDEFRVWKILVElslGLRFIHDHHFVHLDLKPANVLITF 141

                  ....*....
gi 2024423680 486 GGKIYLADF 494
Cdd:cd14052   142 EGTLKIGDF 150
STKc_DRAK cd14106
Catalytic domain of the Serine/Threonine Kinase, Death-associated protein kinase-Related ...
396-503 3.10e-03

Catalytic domain of the Serine/Threonine Kinase, Death-associated protein kinase-Related Apoptosis-inducing protein Kinase; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. DRAKs, also called STK17, were named based on their similarity (around 50% identity) to the kinase domain of DAPKs. They contain an N-terminal kinase domain and a C-terminal regulatory domain. Vertebrates contain two subfamily members, DRAK1 and DRAK2. Both DRAKs are localized to the nucleus, autophosphorylate themselves, and phosphorylate myosin light chain as a substrate. They may play a role in apoptotic signaling. The DRAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271008 [Multi-domain]  Cd Length: 268  Bit Score: 40.03  E-value: 3.10e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 396 RAEGVKEKTFLDQCGSCEHLLKLFQSEQEKGCMYLCFTLWEKNLEEHLQDPED---QKDYKGILKMIFQAVRELHSLGFA 472
Cdd:cd14106    51 RNEILHEIAVLELCKDCPRVVNLHEVYETRSELILILELAAGGELQTLLDEEEcltEADVRRLMRQILEGVQYLHERNIV 130
                          90       100       110
                  ....*....|....*....|....*....|....
gi 2024423680 473 HQALHPKNFL---IDLGGKIYLADFDNTRKLTEG 503
Cdd:cd14106   131 HLDLKPQNILltsEFPLGDIKLCDFGISRVIGEG 164
PHA02876 PHA02876
ankyrin repeat protein; Provisional
36-149 3.18e-03

ankyrin repeat protein; Provisional


Pssm-ID: 165207 [Multi-domain]  Cd Length: 682  Bit Score: 40.82  E-value: 3.18e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  36 REKVLELLENGADVNSKVEFGWTPLHSAVQSGDKEMVQLLLDKGACPHARKDNGGTVfIEAAMVGNVEILEL--LFGCGF 113
Cdd:PHA02876  355 KDIVITLLELGANVNARDYCDKTPIHYAAVRNNVVIINTLLDYGADIEALSQKIGTA-LHFALCGTNPYMSVktLIDRGA 433
                          90       100       110
                  ....*....|....*....|....*....|....*..
gi 2024423680 114 NINDSDNNGFTAFMEAAWYG-KEEALRFLHSKGADVN 149
Cdd:PHA02876  434 NVNSKNKDLSTPLHYACKKNcKLDVIEMLLDNGADVN 470
STKc_Pat1_like cd13993
Catalytic domain of Fungal Pat1-like Serine/Threonine kinases; STKs catalyze the transfer of ...
446-494 3.23e-03

Catalytic domain of Fungal Pat1-like Serine/Threonine kinases; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This subfamily is composed of Schizosaccharomyces pombe Pat1 (also called Ran1), Saccharomyces cerevisiae VHS1 and KSP1, and similar fungal STKs. Pat1 blocks Mei2, an RNA-binding protein which is indispensable in the initiation of meiosis. Pat1 is inactivated and Mei2 activated, which initiates meiosis, under nutrient-deprived conditions through a signaling cascade involving Ste11. Meiosis induced by Pat1 inactivation may show different characteristics than normal meiosis including aberrant positioning of centromeres. VHS1 was identified in a screen for suppressors of cell cycle arrest at the G1/S transition, while KSP1 may be involved in regulating PRP20, which is required for mRNA export and maintenance of nuclear structure. The Pat1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270895 [Multi-domain]  Cd Length: 267  Bit Score: 40.03  E-value: 3.23e-03
                          10        20        30        40        50
                  ....*....|....*....|....*....|....*....|....*....|
gi 2024423680 446 PEDQKDYKGILKMIFQAVRELHSLGFAHQALHPKNFLIDL-GGKIYLADF 494
Cdd:cd13993   103 VGKTELIKNVFLQLIDAVKHCHSLGIYHRDIKPENILLSQdEGTVKLCDF 152
PHA02798 PHA02798
ankyrin-like protein; Provisional
178-297 3.27e-03

ankyrin-like protein; Provisional


Pssm-ID: 222931 [Multi-domain]  Cd Length: 489  Bit Score: 40.59  E-value: 3.27e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 178 FSVVKTLIQeMGADVNICDNEGRNALIHALKDYQRGKSESDVFeigRFLLDHGIDVNCKDEAGRTALILAVQRKNTSLVK 257
Cdd:PHA02798   51 TDIVKLFIN-LGANVNGLDNEYSTPLCTILSNIKDYKHMLDIV---KILIENGADINKKNSDGETPLYCLLSNGYINNLE 126
                          90       100       110       120
                  ....*....|....*....|....*....|....*....|....*
gi 2024423680 258 ALLDREDINIDDA--DEDGQTALMVAVEKNAY---DIAEMLCKKG 297
Cdd:PHA02798  127 ILLFMIENGADTTllDKDGFTMLQVYLQSNHHidiEIIKLLLEKG 171
PHA03095 PHA03095
ankyrin-like protein; Provisional
36-105 3.58e-03

ankyrin-like protein; Provisional


Pssm-ID: 222980 [Multi-domain]  Cd Length: 471  Bit Score: 40.39  E-value: 3.58e-03
                          10        20        30        40        50        60        70
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680  36 REKVLELLENGADVNSKVEFGWTPLHSAVQSGDKEMVQLLLDKGACPHARKDNGGTVFIEAAMVGNVEIL 105
Cdd:PHA03095  237 RSLVLPLLIAGISINARNRYGQTPLHYAAVFNNPRACRRLIALGADINAVSSDGNTPLSLMVRNNNGRAV 306
STKc_LATS cd05598
Catalytic domain of the Serine/Threonine Kinase, Large Tumor Suppressor; STKs catalyze the ...
461-494 3.78e-03

Catalytic domain of the Serine/Threonine Kinase, Large Tumor Suppressor; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270749 [Multi-domain]  Cd Length: 333  Bit Score: 39.99  E-value: 3.78e-03
                          10        20        30
                  ....*....|....*....|....*....|....
gi 2024423680 461 QAVRELHSLGFAHQALHPKNFLIDLGGKIYLADF 494
Cdd:cd05598   112 CAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDF 145
STKc_BUR1 cd07866
Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase (CDK), ...
420-524 3.97e-03

Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase (CDK), Bypass UAS Requirement 1, and similar proteins; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. BUR1, also called SGV1, is a yeast CDK that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270849 [Multi-domain]  Cd Length: 311  Bit Score: 39.99  E-value: 3.97e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 420 QSEQEKGCMYLCFTLWEKNLEEHLQDPE---DQKDYKGILKMIFQAVRELHSLGFAHQALHPKNFLIDLGGKIYLADFDN 496
Cdd:cd07866    82 KSKRKRGSVYMVTPYMDHDLSGLLENPSvklTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGL 161
                          90       100
                  ....*....|....*....|....*...
gi 2024423680 497 TRKLTEGKTELINKDLENLSKLMLYVLT 524
Cdd:cd07866   162 ARPYDGPPPNPKGGGGGGTRKYTNLVVT 189
TRPV5-6 cd22192
Transient Receptor Potential channel, Vanilloid subfamily (TRPV), types 5 and 6; TRPV5 and ...
39-92 4.20e-03

Transient Receptor Potential channel, Vanilloid subfamily (TRPV), types 5 and 6; TRPV5 and TRPV6 (TRPV5/6) are two homologous members within the vanilloid subfamily of the transient receptor potential (TRP) family. TRPV5 and TRPV6 show only 30-40% homology with other members of the TRP family and have unique properties that differentiates them from other TRP channels. They mediate calcium uptake in epithelia and their expression is dramatically increased in numerous types of cancer. The structure of TRPV5/6 shows the typical topology features of all TRP family members, such as six transmembrane regions, a short hydrophobic stretch between transmembrane segments 5 and 6, which is predicted to form the Ca2+ pore, and large intracellular N- and C-terminal domains. The N-terminal domain of TRPV5/6 contains three ankyrin repeats. This structural element is present in several proteins and plays a role in protein-protein interactions. The N- and C-terminal tails of TRPV5/6 each contain an internal PDZ motif which can function as part of a molecular scaffold via interaction with PDZ-domain containing proteins. A major difference between the properties of TRPV5 and TRPV6 is in their tissue distribution: TRPV5 is predominantly expressed in the distal convoluted tubules (DCT) and connecting tubules (CNT) of the kidney, with limited expression in extrarenal tissues. In contrast, TRPV6 has a broader expression pattern such as expression in the intestine, kidney, placenta, epididymis, exocrine tissues, and a few other tissues.


Pssm-ID: 411976 [Multi-domain]  Cd Length: 609  Bit Score: 40.38  E-value: 4.20e-03
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 2024423680  39 VLELLENGADVNS--------------KVEFGWTPLHSAVQSGDKEMVQLLLDKGACPHARKDNGGTV 92
Cdd:cd22192   105 VRELIARGADVVSpratgtffrpgpknLIYYGEHPLSFAACVGNEEIVRLLIEHGADIRAQDSLGNTV 172
STKc_ROCK cd05596
Catalytic domain of the Serine/Threonine Kinase, Rho-associated coiled-coil containing protein ...
462-494 4.58e-03

Catalytic domain of the Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270747 [Multi-domain]  Cd Length: 352  Bit Score: 40.05  E-value: 4.58e-03
                          10        20        30
                  ....*....|....*....|....*....|...
gi 2024423680 462 AVRELHSLGFAHQALHPKNFLIDLGGKIYLADF 494
Cdd:cd05596   137 ALDAIHSMGFVHRDVKPDNMLLDASGHLKLADF 169
STKc_EIF2AK cd13996
Catalytic domain of the Serine/Threonine kinase, eukaryotic translation Initiation Factor ...
428-514 4.58e-03

Catalytic domain of the Serine/Threonine kinase, eukaryotic translation Initiation Factor 2-Alpha Kinase; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. EIF2AKs phosphorylate the alpha subunit of eIF-2, resulting in the downregulation of protein synthesis. eIF-2 phosphorylation is induced in response to cellular stresses including virus infection, heat shock, nutrient deficiency, and the accummulation of unfolded proteins, among others. There are four distinct kinases that phosphorylate eIF-2 and control protein synthesis under different stress conditions: General Control Non-derepressible-2 (GCN2) which is activated during amino acid or serum starvation; protein kinase regulated by RNA (PKR) which is activated by double stranded RNA; heme-regulated inhibitor kinase (HRI) which is activated under heme-deficient conditions; and PKR-like endoplasmic reticulum kinase (PERK) which is activated when misfolded proteins accumulate in the ER. The EIF2AK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270898 [Multi-domain]  Cd Length: 273  Bit Score: 39.58  E-value: 4.58e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 428 MYLCFTlweKNLEEHLQDP-----EDQKDYKGILKMIFQAVRELHSLGFAHQALHPKNFLIDLG-GKIYLADFDNTRKLT 501
Cdd:cd13996    83 MELCEG---GTLRDWIDRRnssskNDRKLALELFKQILKGVSYIHSKGIVHRDLKPSNIFLDNDdLQVKIGDFGLATSIG 159
                          90
                  ....*....|...
gi 2024423680 502 EGKTELINKDLEN 514
Cdd:cd13996   160 NQKRELNNLNNNN 172
STKc_MOK cd07831
Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase; STKs ...
412-498 4.65e-03

Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270825 [Multi-domain]  Cd Length: 282  Bit Score: 39.56  E-value: 4.65e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 412 CEHLLklfqsEQEKGCMYLCFTLWEKNLEEHLQD---PEDQKDYKGILKMIFQAVRELHSLGFAHQALHPKNFLIDlGGK 488
Cdd:cd07831    64 IEVLF-----DRKTGRLALVFELMDMNLYELIKGrkrPLPEKRVKNYMYQLLKSLDHMHRNGIFHRDIKPENILIK-DDI 137
                          90
                  ....*....|
gi 2024423680 489 IYLADFDNTR 498
Cdd:cd07831   138 LKLADFGSCR 147
PTZ00024 PTZ00024
cyclin-dependent protein kinase; Provisional
453-499 5.21e-03

cyclin-dependent protein kinase; Provisional


Pssm-ID: 240233 [Multi-domain]  Cd Length: 335  Bit Score: 39.74  E-value: 5.21e-03
                          10        20        30        40
                  ....*....|....*....|....*....|....*....|....*..
gi 2024423680 453 KGILKMIFQAVRELHSLGFAHQALHPKNFLIDLGGKIYLADFDNTRK 499
Cdd:PTZ00024  122 KCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARR 168
Ank_4 pfam13637
Ankyrin repeats (many copies);
168-208 5.24e-03

Ankyrin repeats (many copies);


Pssm-ID: 372654 [Multi-domain]  Cd Length: 54  Bit Score: 35.71  E-value: 5.24e-03
                          10        20        30        40
                  ....*....|....*....|....*....|....*....|.
gi 2024423680 168 ALMDACWGGHFSVVKTLIQEmGADVNICDNEGRNALIHALK 208
Cdd:pfam13637   4 ALHAAAASGHLELLRLLLEK-GADINAVDGNGETALHFAAS 43
ChoK-like cd05151
Choline Kinase and similar proteins; This subfamily is composed of bacterial and eukaryotic ...
437-495 5.32e-03

Choline Kinase and similar proteins; This subfamily is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate and displays negligible activity towards N-methylated derivatives of Etn. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K).


Pssm-ID: 270700 [Multi-domain]  Cd Length: 152  Bit Score: 37.92  E-value: 5.32e-03
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|....
gi 2024423680 437 KNLEEHLQDPEdqkdykgILKMIFQAVRELHSLG-----FAHQALHPKNFLIDlGGKIYLADFD 495
Cdd:cd05151    77 TLLTNDFSDPE-------NLERIAALLRKLHSSPledlvLCHNDLVPGNFLLD-DDRLYLIDWE 132
STKc_HAL4_like cd13994
Catalytic domain of Fungal Halotolerance protein 4-like Serine/Threonine kinases; STKs ...
418-494 5.68e-03

Catalytic domain of Fungal Halotolerance protein 4-like Serine/Threonine kinases; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This subfamily is composed of HAL4, Saccharomyces cerevisiae Ptk2/Stk2, and similar fungal proteins. Proteins in this subfamily are involved in regulating ion transporters. In budding and fission yeast, HAL4 promotes potassium ion uptake, which increases cellular resistance to other cations such as sodium, lithium, and calcium ions. HAL4 stabilizes the major high-affinity K+ transporter Trk1 at the plasma membrane under low K+ conditions, which prevents endocytosis and vacuolar degradation. Budding yeast Ptk2 phosphorylates and regulates the plasma membrane H+ ATPase, Pma1. The HAL4-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270896 [Multi-domain]  Cd Length: 265  Bit Score: 39.21  E-value: 5.68e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2024423680 418 LFQSEQEKGC--MYLC-----FTLWEKnleehlQDPEDQKDYKGILKMIFQAVRELHSLGFAHQALHPKNFLIDLGGKIY 490
Cdd:cd13994    65 LCQDLHGKWClvMEYCpggdlFTLIEK------ADSLSLEEKDCFFKQILRGVAYLHSHGIAHRDLKPENILLDEDGVLK 138

                  ....
gi 2024423680 491 LADF 494
Cdd:cd13994   139 LTDF 142
PRK01723 PRK01723
3-deoxy-D-manno-octulosonic-acid kinase; Reviewed
459-495 7.03e-03

3-deoxy-D-manno-octulosonic-acid kinase; Reviewed


Pssm-ID: 234975  Cd Length: 239  Bit Score: 38.71  E-value: 7.03e-03
                          10        20        30
                  ....*....|....*....|....*....|....*..
gi 2024423680 459 IFQAVRELHSLGFAHQALHPKNFLIDLGGKIYLADFD 495
Cdd:PRK01723  151 IGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFD 187
PLN02421 PLN02421
phosphotransferase, alcohol group as acceptor/kinase
432-495 8.25e-03

phosphotransferase, alcohol group as acceptor/kinase


Pssm-ID: 215231 [Multi-domain]  Cd Length: 330  Bit Score: 38.95  E-value: 8.25e-03
                          10        20        30        40        50        60        70
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 2024423680 432 FTLWEKNLEEHLQDPEDQKDYKGI-LKMIFQAVRELHSLG--------FAHQALHPKNFLI-DLGGKIYLADFD 495
Cdd:PLN02421  136 FKFYEKASTVKFEDPEKQKKYETIsFEELRDEIVELKEITdslkapvvFAHNDLLSGNLMLnEDEGKLYFIDFE 209
ANK smart00248
ankyrin repeats; Ankyrin repeats are about 33 amino acids long and occur in at least four ...
121-150 9.21e-03

ankyrin repeats; Ankyrin repeats are about 33 amino acids long and occur in at least four consecutive copies. They are involved in protein-protein interactions. The core of the repeat seems to be an helix-loop-helix structure.


Pssm-ID: 197603 [Multi-domain]  Cd Length: 30  Bit Score: 34.10  E-value: 9.21e-03
                           10        20        30
                   ....*....|....*....|....*....|
gi 2024423680  121 NGFTAFMEAAWYGKEEALRFLHSKGADVNM 150
Cdd:smart00248   1 DGRTPLHLAAENGNLEVVKLLLDKGADINA 30
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH